Nordson (NDSN) 10-K 18 Dec 24 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Oct. 31, 2024	Nov. 30, 2024	Apr. 30, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Oct. 31, 2024
Current Fiscal Year End Date	--10-31
Document Transition Report	false
Entity File Number	0-7977
Entity Registrant Name	NORDSON CORPORATION
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	34-0590250
Entity Address, Address Line One	28601 Clemens Road
Entity Address, City or Town	Westlake
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44145
City Area Code	440
Local Phone Number	892-1580
Title of 12(b) Security	Common Shares, without par value
Trading Symbol	NDSN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 14,758,563,021
Entity Common Stock, Shares Outstanding		57,016,026
Entity Common Stock, Shares Outstanding		57,016,026
Documents Incorporated by Reference	Portions of the Definitive Proxy Statement for the 2025 Annual Meeting of Shareholders - Part III of the Form 10-K
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Entity Central Index Key	0000072331

Audit Information

Audit Information	12 Months Ended
	Oct. 31, 2024
Audit Information [Abstract]
Auditor Location	Cleveland, Ohio
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Income Statement [Abstract]
Sales	$ 2,689,921	$ 2,628,632	$ 2,590,278
Operating costs and expenses:
Cost of sales	1,203,792	1,203,227	1,163,742
Selling and administrative expenses	812,128	752,644	724,176
Total operating costs and expenses	2,015,920	1,955,871	1,887,918
Operating profit	674,001	672,761	702,360
Other income (expense):
Interest expense	(88,924)	(59,505)	(22,413)
Interest and investment income	4,913	2,680	2,026
Pension settlement charge for U.S. Plans	0	0	(41,221)
Other - net	(4,509)	(597)	8,527
Total other income (expense)	(88,520)	(57,422)	(53,081)
Income before income taxes	585,481	615,339	649,279
Income tax expense	118,197	127,846	136,176
Net income	$ 467,284	$ 487,493	$ 513,103
Average common shares (in shares)	57,176	57,090	57,629
Incremental common shares attributable to outstanding stock options, restricted stock and deferred stock-based compensation (in shares)	440	541	620
Average common shares and common share equivalents (in shares)	57,616	57,631	58,249
Basic earnings per share (in dollars per share)	$ 8.17	$ 8.54	$ 8.90
Diluted earnings per share (in dollars per share)	8.11	8.46	8.81
Dividends declared per common share (in dollars per share)	$ 2.82	$ 2.63	$ 2.18

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 467,284	$ 487,493	$ 513,103
Components of other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	16,390	26,766	(126,657)
Pension and postretirement benefit plans:
Net actuarial gain (loss) arising during the year	(4,387)	(15,106)	54,065
Amortization of prior service cost	(7)	(34)	(201)
Amortization of actuarial (gain) loss	(502)	(24)	7,575
Curtailment gain (loss)	0	(2)	1,052
Settlement (gain) loss recognized	107	(259)	32,219
Total pension and postretirement benefit plans	(4,789)	(15,425)	94,710
Total other comprehensive income (loss)	11,601	11,341	(31,947)
Total comprehensive income	$ 478,885	$ 498,834	$ 481,156

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Current assets:
Cash and cash equivalents	$ 115,952	$ 115,679
Receivables - net	594,663	590,886
Inventories - net	476,935	454,775
Prepaid expenses and other current assets	87,482	67,970
Total current assets	1,275,032	1,229,310
Goodwill	3,280,819	2,784,201
Property, plant and equipment - net	544,607	392,846
Intangible assets - net	740,846	672,744
Operating right of use lease assets	93,620	106,176
Deferred income taxes	11,196	16,022
Other assets	54,846	50,471
Total assets	6,000,966	5,251,770
Current liabilities:
Current maturities of long-term debt and notes payable	103,928	115,662
Accrued liabilities	225,231	199,588
Accounts payable	97,839	106,320
Customer advance payments	46,400	93,389
Income taxes payable	32,754	45,359
Operating lease liability - current	17,063	16,853
Finance lease liability	5,262	4,918
Total current liabilities	528,477	582,089
Long-term debt	2,101,197	1,621,394
Operating lease liability - noncurrent	80,818	92,412
Deferred income taxes	205,687	210,637
Postretirement obligations	51,544	50,862
Pension obligations	46,893	40,425
Finance lease liability - noncurrent	12,083	11,670
Other long-term liabilities	42,075	44,221
Shareholders' equity:
Preferred shares, no par value; 10,000 shares authorized; none issued	0	0
Common shares, no par value; 160,000 shares authorized; 98,023 shares issued at October 31, 2021 and 2020	12,253	12,253
Capital in excess of stated value	714,091	668,097
Retained earnings	4,295,199	3,989,353
Accumulated other comprehensive loss	(184,840)	(196,441)
Common shares in treasury, at cost	(1,904,511)	(1,875,202)
Total shareholders' equity	2,932,192	2,598,060
Total liabilities and shareholders' equity	$ 6,000,966	$ 5,251,770

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares	Oct. 31, 2024	Oct. 31, 2023
Statement of Financial Position [Abstract]
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Common shares, authorized (in shares)	160,000,000	160,000,000
Common shares, issued (in shares)	98,023,000	98,023,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in- Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Common Shares in Treasury, at cost
Beginning Balance at Oct. 31, 2021	$ 2,159,130	$ 12,253	$ 585,334	$ 3,265,027	$ (175,835)	$ (1,527,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	12,124		10,615			1,509
Stock-based compensation	30,748		30,748
Purchase of treasury shares, value	(262,869)					(262,869)
Dividends declared	(125,914)			(125,914)
Net income	513,103			513,103
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(126,657)				(126,657)
Pension plan settlement adjustment	33,271				33,271
Defined benefit pension and post-retirement plans adjustment	61,439				61,439
Ending Balance at Oct. 31, 2022	2,294,375	12,253	626,697	3,652,216	(207,782)	(1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	21,373		17,858			3,515
Stock-based compensation	23,542		23,542
Purchase of treasury shares, value	(89,708)					(89,708)
Dividends declared	(150,356)			(150,356)
Net income	487,493			487,493
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	26,766				26,766
Defined benefit pension and post-retirement plans adjustment	(15,425)				(15,425)
Ending Balance at Oct. 31, 2023	2,598,060	12,253	668,097	3,989,353	(196,441)	(1,875,202)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	31,067		27,037			4,030
Stock-based compensation	18,957		18,957
Purchase of treasury shares, value	(33,339)					(33,339)
Dividends declared	(161,438)			(161,438)
Net income	467,284			467,284
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	16,390				16,390
Defined benefit pension and post-retirement plans adjustment	(4,789)				(4,789)
Ending Balance at Oct. 31, 2024	$ 2,932,192	$ 12,253	$ 714,091	$ 4,295,199	$ (184,840)	$ (1,904,511)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 2.82	$ 2.63	$ 2.18

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities:
Net income	$ 467,284	$ 487,493	$ 513,103
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	59,203	52,179	49,098
Amortization	76,972	59,719	50,825
Provision for losses on receivables	619	283	1,259
Deferred income taxes	(18,557)	(16,116)	(10,732)
Non-cash stock compensation	18,957	22,710	30,748
Loss (gain) on sale of property, plant and equipment	1,468	1,092	(581)
Pension settlement charge for U.S. Plans	0	0	41,221
Other non-cash	3,396	8,136	1,259
Changes in operating assets and liabilities:
Receivables	13,988	18,185	(72,907)
Inventories	46,615	22,418	(69,132)
Prepaid expenses	(4,543)	(14,677)	(1,708)
Accounts payable	(38,591)	(15,820)	10,671
Income taxes payable	(19,385)	17,722	6,155
Accrued liabilities	8,187	(28,620)	925
Customer advance payments	(48,425)	(2,779)	18,682
Other	(10,995)	29,357	(55,755)
Net cash provided by operating activities	556,193	641,282	513,131
Cash flows from investing activities:
Additions to property, plant and equipment	(64,410)	(34,583)	(51,428)
Proceeds from sale of property, plant and equipment	75	101	280
Acquisition of businesses, net of cash acquired	(789,996)	(1,422,780)	(171,613)
Other	9,933	20,383	0
Net cash used in investing activities	(844,398)	(1,436,879)	(222,761)
Cash flows from financing activities:
Proceeds from issuance of debt	783,039	2,178,596	63,067
Repayment of debt	(318,686)	(1,202,553)	(96,975)
Repayment of capital lease obligations	(6,148)
Repayment of capital lease obligations		(6,840)	(5,439)
Issuance of common shares	31,067	21,373	12,124
Purchase of treasury shares	(33,339)	(89,708)	(262,869)
Dividends paid	(161,438)	(150,356)	(125,914)
Net cash provided (used) in financing activities	294,495	750,512	(416,006)
Effect of exchange rate changes on cash	(6,017)	(2,693)	(10,879)
Increase (decrease) in cash and cash equivalents	273	(47,778)	(136,515)
Cash and cash equivalents at beginning of year	115,679	163,457	299,972
Cash and cash equivalents at end of year	$ 115,952	$ 115,679	$ 163,457

Significant accounting policies

Significant accounting policies	12 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Significant accounting policies	Significant accounting policies Consolidation — The consolidated financial statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50 percent or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of estimates — The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and notes. Actual amounts could differ from these estimates. Fiscal year — Our fiscal year is November 1 through October 31. Revenue recognition — A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of October 31, 2024 and 2023 were not material. However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at October 31, 2024 or 2023. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for October 31, 2024 and 2023. Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Consolidated Statements of Income. We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, therefore, these items are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to Note 14 for details on our operating segments. Shipping and handling costs — Amounts billed to customers for shipping and handling are recorded as revenue. Shipping and handling expenses are included in cost of sales. Advertising costs — Advertising costs are expensed as incurred and we re $8,923, $7,635 and $7,028 in 2024, 2023 and 2022, respectively. Research and development — Investments in research and development are important to our long-term growth, enabling us to keep pace with changing customer and marketplace needs through the development of new products and new applications for existing products. We place strong emphasis on technology developments and improvements through internal engineering and research teams. Research and development costs are expensed as incurred and were $64,992 , $71,400 and $52,531 in 2024, 2023 and 2022, respectively. Earnings per share — Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted stock and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options f or 74 c ommon shares were excluded from the diluted earnings per share calculation in 2024 and 140 and 78 options were excluded from the calculation of diluted earnings per share in 2023 and 2022, respectively, because their effect would have been anti-dilutive. Under the 2021 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share. Cash and cash equivalents — Highly liquid instruments with maturities of 90 days or less at date of purchase are considered to be cash equivalents. Allowance for doubtful accounts — An allowance for doubtful accounts is maintained for estimated losses resulting from the inability of customers to make required payments. The amount of the allowance is determined principally on the basis of past collection experience and known factors regarding specific customers. Accounts are written off against the allowance when it becomes evident that collection will not occur. Credit is extended to customers satisfying pre-defined credit criteria. We believe we have limited concentration of credit risk due to the diversity of our customer base. Our primary allowance for credit losses is the allowance for doubtful accounts, which is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible. Accounts receivable are net of an allowance for credit losses of $9,769 and $10,015 at October 31, 2024 and October 31, 2023, respectively. The provision for losses on receivables was $619 for the twelve months ended October 31, 2024 compared to $283 for the same period a year ago. The remaining change in the allowance for credit losses is principally related to increases due to acquisitions and the write-off of uncollectible accounts. Inventories — Inventories are valued at the lower of cost or net realizable value. Effective in the third quarter of 2022, we changed our accounting method for certain U.S. inventories from a last-in, first-out basis ("LIFO") to a first-in, first-out basis. Previously, the LIFO method was used to determine the cost of a portion of our inventories in the U.S. We believe this change in accounting method is preferable as it is consistent with how we manage our business, results in a uniform method to value our inventory across all regions of our business, improves comparability with our peers and is expected to better reflect the current value of inventory on the consolidated balance sheets. We applied this accounting change as a cumulative effect adjustment to cost of sales in the third quarter of 2022 and did not restate prior period financial statements because the impact was not material. Derivatives — The Company does not enter into derivative financial instruments for trading purposes. Derivative instruments are used to manage risks associated with foreign exchange rates. We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. The settlement of these contracts is recorded in operating activities on the Consolidated Statements of Cash Flows. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. These hedges are included on the balance sheet at fair value. Changes in the fair value of derivative assets or liabilities (i.e., gains or losses) are recognized depending upon the type of hedging relationship and whether a hedge has been designated. For derivative instruments that qualify for hedge accounting and are used to hedge net assets of certain foreign subsidiaries, we designate the hedging instrument as a hedge of a net investment in a foreign operation with the effective portion of the derivative's gain or loss reported in Accumulated other comprehensive loss as part of the cumulative translation adjustment and amounts reclassified out of accumulated other comprehensive loss into earnings when the hedged net investment is either sold or substantially liquidated. The settlement of these hedges is recorded in investing activities on the Consolidated Statement of Cash Flows. Changes in fair value of derivative instruments that do not qualify for hedge accounting are recognized immediately in current net earnings in "Other-net" on the Consolidated Statements of Income. The Company has entered into treasury locks to fix the interest rate related to notes issued. The derivative positions are closed when the debt is priced with a cash settlement net payment that offsets changes in the benchmark treasury rate between execution of the treasury rate locks and the debt pricing date. The treasury locks are designed as cash flow hedges and the deferred amounts are reported in Accumulated Other Comprehensive Income (loss) ("AOCI") and subsequently reclassed to interest expense as payments are made on the notes through the maturity date. Property, plant and equipment and depreciation — Property, plant and equipment are carried at cost. Additions and improvements that extend the lives of assets are capitalized, while expenditures for repairs and maintenance are expensed as incurred. Plant and equipment are depreciated for financial reporting purposes using the straight-line method over the estimated useful lives of the assets or, in the case of property under finance leases, over the terms of the leases. Leasehold improvements are depreciated over the shorter of the lease term or their useful lives. Useful lives are as follows: Land improvements 15-25 years Buildings 20-40 years Machinery and equipment 3-18 years Enterprise management systems 5-13 years Depreciation expense is included in Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Internal use software costs are expensed or capitalized depending on whether they are incurred in the preliminary project stage, application development stage or the post-implementation stage. Amounts capitalized are amortized over the estimated useful lives of the software beginning with the project’s completion. All re-engineering costs are expensed as incurred. Interest costs on significant capital projects are capitalized. No interest was capitalized in 2024, 2023 or 2022. Goodwill and intangible assets — Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill relates to and is assigned directly to specific reporting units. Goodwill is not amortized but is subject to annual impairment testing. Our annual impairment testing is performed as of August 1. Testing is done more frequently if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets. The acquisitions of our businesses are accounted for under the acquisition method of accounting. The amounts assigned to the identifiable assets acquired and liabilities assumed in connection with acquisitions are based on estimated fair values as of the date of the acquisition, with the remainder, if any, recorded as goodwill. The fair values are determined by management, taking into consideration information supplied by the management of the acquired entities, and other relevant information. Such information typically includes valuations obtained from independent appraisal experts, which management reviews and considers in its estimates of fair values. The valuations are generally based upon future cash flow projections for the acquired assets, discounted to present value. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future revenue growth rates and EBITDA margins, discount rates, customer attrition rates, and asset lives, among other items. This judgment could result in either a higher or lower value assigned to amortizable or depreciable assets. The impact could result in either higher or lower amortization and/or depreciation expense. Other amortizable intangible assets, which consist primarily of patent/technology costs, customer relationships, non-compete agreements and trade names, are amortized over their useful lives on a straight-line basis. At October 31, 2024, the weighted-average useful lives for each major category of amortizable intangible assets were: Patent/technology costs 11 years Customer relationships 17 years Noncompete agreements 4 years Trade names 10 years Foreign currency translation — The financial statements of subsidiaries outside the United States are generally measured using the local currency as the functional currency. Assets and liabilities of these subsidiaries are translated at the rates of exchange at the balance sheet dates. Income and expense items are translated at average monthly rates of exchange. The resulting translation adjustments are included in AOCI, a separate component of Shareholders’ equity. Generally, gains and losses from foreign currency transactions, including forward contracts, of these subsidiaries and the United States parent are included in net income. Gains and losses from intercompany foreign currency transactions of a long-term investment nature are included in AOCI. Accumulated other comprehensive loss — Accumulated other comprehensive loss at October 31, 2024 and 2023 consisted of: Cumulative Pension and Accumulated Balance at October 31, 2023 $ (133,280) $ (63,161) $ (196,441) Pension and postretirement plan changes, net of tax of $1,716 — (4,789) (4,789) Currency translation losses 16,390 — 16,390 Balance at October 31, 2024 $ (116,890) $ (67,950) $ (184,840) Warranties — We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets. Following is a reconciliation of the product warranty liability as of October 31, 2024 and 2023: 2024 2023 Balance at beginning of year $ 14,401 $ 11,723 Accruals for warranties 14,965 20,910 Warranty payments (15,717) (16,171) Currency adjustments (111) (2,061) Balance at end of year $ 13,538 $ 14,401

Recently Issued Accounting Stan

Recently Issued Accounting Standards	12 Months Ended
	Oct. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Recently Issued Accounting Standards	Note 2 — Recently issued accounting standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 requires enhanced disclosures about significant segment expenses and enhanced disclosures in interim periods. The guidance in ASU 2023-07 will be applied retrospectively and is effective for annual reporting periods in fiscal years beginning after December 15, 2023 and interim reporting periods in fiscal years beginning after December 31, 2024, with early adoption permitted. The Company is currently evaluating the impact that the adoption of ASU 2023-07 will have on its consolidated financial statements and disclosures and anticipates adoption in 2025. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . ASU 2023-09 is intended to improve income tax disclosure requirements by requiring specific disclosure in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold. The guidance in ASU 2023-09 will be effective for annual reporting periods in fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact that the adoption of ASU 2023-09 will have on its consolidated financial statements and disclosures and anticipates adoption in fiscal 2026.

Acquisitions

Acquisitions	12 Months Ended
	Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Note 3 — Acquisitions Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Consolidated Statements of Income. 2024 Acquisition On August 21, 2024, the Company completed the acquisition of Atrion Corporation, a Delaware corporation (“Atrion”), pursuant to the terms of the Agreement and Plan of Merger (the “Merger Agreement”), dated May 28, 2024, with Alpha Medical Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Nordson (“Merger Sub”), and Atrion. Pursuant to the Merger Agreement, Merger Sub merged with and into Atrion (the “Merger”), with Atrion surviving the Merger as a wholly owned subsidiary of Nordson. Atrion is a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions and will operate within our Medical and Fluid Solutions segment. The all-cash acquisition of Atrion of $789,996, net of cash acquired, was funded using borrowings under our revolving credit facility and the 364-day term loan agreement with a group of banks for a delayed draw term loan facility in the aggregate principal amount of $500,000 (the “364-Day Term Loan Agreement”) (see Note 8 to the Consolidated Financial Statements for additional details) and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, a preliminary purchase price allocation resulted in the recognition of $494,279 of goodwill and $129,600 of identifiable intangible assets. The identifiable intangible assets consist primarily of $40,100 of tradenames (amortized over 15 years), $24,900 of technology (amortized over 15 years), and $64,600 of customer relationships (amortized over 19 years). Goodwill associated with the acquisition was not tax deductible. As of October 31, 2024, the purchase price allocation remains preliminary as we complete our assessment, principally related to income taxes. The financial results of the Atrion acquisition are not expected to have a material impact on our Consolidated Financial Statements. The assets and liabilities acquired were as follows: August 21, 2024 Cash $ 24,428 Receivables - net 20,883 Inventories - net 64,801 Goodwill 494,279 Intangibles 129,600 Other assets 158,059 Total Assets $ 892,050 Accounts payable $ 25,587 Deferred income taxes 31,221 Other liabilities 20,818 Total Liabilities $ 77,626 2023 Acquisitions On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries ("ARAG Group" or "ARAG") pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP, DRIP Co-Investment, and certain individuals. ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG operates as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the “364-Day Term Loan Facility”). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using borrowings under the 364-Day Term Loan Facility and the Company's revolving credit facility. The 364-Day Term Loan Facility was subsequentially paid off in September 2023 with the net proceeds of a senior notes offering (see Note 8 to the Consolidated Financial Statements for additional details). Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $684,938 and identifiable intangible assets of $353,500 were recorded. The identifiable intangible assets consist primarily of $27,500 of tradenames (amortized over 9 years ), $31,000 of technology (amortized over 5 years ), and $295,000 of customer relationships (amortized over 22 years ). Goodwill associated with the acquisition was not tax deductible. As of October 31, 2024, the purchase price allocation is final. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements. The assets and liabilities acquired were as follows: August 24, 2023 Cash $ 32,966 Receivables - net 31,081 Inventories - net 54,252 Goodwill 684,938 Intangibles 353,500 Other assets 55,963 Total Assets $ 1,212,700 Accounts payable $ 18,915 Deferred income taxes 100,097 Other liabilities 15,785 Total Liabilities $ 134,797 On November 3, 2022, we acquired 100% of CyberOptics Corporation ("CyberOptics"). CyberOptics is a leading global developer and manufacturer of high-precision 3D optical s ensing technology solutions. The CyberOptics acquisition expanded our test and inspection platform, providing differentiated technology that expands our product offering in the semiconductor and electronics industries and is reported in our Advanced Technology Solutions segment. We acquired CyberOptics for an aggregate purchase price of $377,843, net of cash of approximately $40,890, funded using borrowings under our revolving credit facility and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $285,330 and identifiable intangible assets of $58,600 were recorded. The identifiable intangible assets consist primarily of $15,200 of tradenames (amortized over 15 years), $14,600 of technology (amortized over 7 years), and $28,800 of customer relationships (amortized over 12 years). Goodwill associated with the acquisition was not tax deductible . As of October 31, 2024, the purchase price allocation was final. The financial results of CyberOptics are not material to our Consolidated Financial Statements. The assets and liabilities acquired were as follows: November 3, 2022 Cash $ 40,890 Receivables - net 21,364 Inventories - net 33,639 Goodwill 285,330 Intangibles 58,600 Other assets 13,768 Total Assets $ 453,591 Accounts payable $ 8,109 Deferred income taxes 14,826 Other liabilities 11,923 Total Liabilities $ 34,858 2022 Acquisition On November 1, 2021, we acquired 100%

Details of Consolidated Balance

Details of Consolidated Balance Sheet	12 Months Ended
	Oct. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Details of Consolidated Balance Sheet	Note 4 — Details of Consolidated Balance Sheet 2024 2023 Receivables: Accounts $ 571,381 $ 558,393 Notes 595 662 Other 32,456 41,845 604,432 600,901 Allowance for doubtful accounts (9,769) (10,015) $ 594,663 $ 590,886 Inventories: Finished goods $ 256,465 $ 233,552 Raw materials and component parts 250,477 211,874 Work-in-process 55,790 86,474 562,732 531,900 Obsolescence and other reserves (85,797) (77,125) $ 476,935 $ 454,775 Property, plant and equipment: Land $ 32,018 $ 15,792 Land improvements 4,822 5,019 Buildings 354,854 294,267 Machinery and equipment 649,510 549,291 Enterprise management system 53,401 52,939 Construction-in-progress 58,362 24,916 Leased property under finance leases 29,404 28,406 1,182,371 970,630 Accumulated depreciation (637,764) (577,784) $ 544,607 $ 392,846 Accrued liabilities: Salaries and other compensation $ 77,799 $ 63,130 Interest 13,800 11,240 Taxes other than income taxes 13,560 14,894 Warranty 13,538 14,401 Net Investment Contracts 10,675 — Pension and other employee benefits 8,919 8,686 Commissions and rebates 6,844 8,823 Foreign currency forward contracts 5,508 10,425 Other 74,588 67,989 $ 225,231 $ 199,588

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and intangible assets We account for goodwill and other intangible assets in accordance with the provisions of ASC 350 and account for business combinations using the acquisition method of accounting and accordingly, the assets and liabilities of the entities acquired are recorded at their estimated fair values at the acquisition date. Goodwill is the excess of purchase price over the fair value of tangible and identifiable intangible net assets acquired in various business combinations. Goodwill is not amortized but is subject to annual impairment testing. Our annual impairment testing is performed as of August 1. Testing is done more frequently if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets. We assess the fair value of reporting units on a non-recurring basis using a quantitative analysis that uses a combination of the Income Approach and the guideline public company method of the Market Approach, and compare the result against the reporting unit’s carrying value of net assets. The implied fair value of our reporting units is determined based on significant unobservable inputs, as discussed below; accordingly, these inputs fall within Level 3 of the fair value hierarchy. The Income Approach uses assumptions for revenue growth, operating margin and working capital turnover that are based on management’s strategic plans tempered by performance trends and reasonable expectations about those trends. Terminal value calculations employ a published formula known as the Gordon Growth Model Method that essentially captures the present value of perpetual cash flows beyond the last projected period assuming a constant Weighted Average Cost of Capital ("WACC") methodology and growth rate. For each reporting unit, a sensitivity analysis is performed to vary the discount and terminal growth rates in order to provide a range of reasonableness for detecting impairment. Discount rates are developed using a WACC methodology. The WACC represents the blended average required rate of return for equity and debt capital based on observed market return data and company specific risk factors. In the application of the guideline public company method, fair value is determined using transactional evidence for similar publicly traded equity. The comparable company guideline group is determined based on relative similarities to each reporting unit since exact correlations are not available. An indication of fair value for each reporting unit is based on the placement of each reporting unit within a range of multiples determined for its comparable guideline company group. Valuation multiples are derived by dividing latest twelve-month performance for revenues and Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") into total invested capital, which is the sum of traded equity plus interest bearing debt less cash. These multiples are applied against the revenue and EBITDA of each reporting unit. While the implied indications of fair value using the guideline public company method yield meaningful results, the discounted cash flow method of the Income Approach includes management’s thoughtful projections and insights as to what the reporting units will accomplish in the near future. Accordingly, the reasonable, implied fair value of each reporting unit is a blend based on the consideration of both the Income and Market approaches. An impairment charge is recorded for the amount by which the carrying value of the reporting unit exceeds the fair value of the reporting unit, as calculated in the quantitative analysis described above. Based on our annual impairment tests in 2024, 2023 and 2022, the fair value of each reporting unit exceeded its carrying value, and accordingly, we did not record any goodwill impairment charges in 2024, 2023 or 2022. Our reporting units include components of the Industrial Precision Solutions, Medical and Fluid Solutions, and the Advanced Technology Solutions segments. Changes in the carrying amount of goodwill during 2024 by operating segment: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Systems Total Balance at October 31, 2023 $ 1,208,996 $ 1,173,858 $ 401,347 $ 2,784,201 Acquisitions (9,962) 494,279 — 484,317 Currency effect 8,597 1,611 2,093 12,301 Balance at October 31, 2024 $ 1,207,631 $ 1,669,748 $ 403,440 $ 3,280,819 The increase in goodwill for 2024 was due to the acquisition of Atrion. See Note 3 to the Consolidated Financial Statements for additional details. Changes in the carrying amount of goodwill during 2023 by operating segment: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Systems Total Balance at October 31, 2022 $ 520,236 $ 1,172,069 $ 112,388 $ 1,804,693 Acquisitions 694,900 — 285,330 980,230 Currency effect (6,140) 1,789 3,629 (722) Balance at October 31, 2023 $ 1,208,996 $ 1,173,858 $ 401,347 $ 2,784,201 The increase in goodwill for 2023 was due to the acquisition of CyberOptics and the ARAG Group. See Note 3 to the Consolidated Financial Statements for additional details. Information regarding intangible assets subject to amortization: October 31, 2024 Carrying Accumulated Net Book Customer relationships $ 878,071 $ 339,756 $ 538,315 Patent/technology costs 232,371 134,187 98,184 Trade names 167,144 62,887 104,257 Noncompete agreements 8,502 8,412 90 Other 500 500 — Total $ 1,286,588 $ 545,742 $ 740,846 October 31, 2023 Carrying Accumulated Net Book Customer relationships $ 794,706 $ 287,585 $ 507,121 Patent/technology costs 204,905 112,994 91,911 Trade names 125,692 52,488 73,204 Noncompete agreements 10,028 9,521 507 Other 182 181 1 Total $ 1,135,513 $ 462,769 $ 672,744 Amortization expense for 2024, 2023 and 2022 was $76,972, $59,719 and $50,825, respectively. See Note 3 for details regarding intangibles recorded due to acquisitions. Estimated amortization expense for each of the five succeeding years: Year Amounts 2025 $ 77,220 2026 $ 73,639 2027 $ 70,807 2028 $ 68,239 2029 $ 62,334

Retirement, Pension and Other P

Retirement, Pension and Other Postretirement Plans	12 Months Ended
	Oct. 31, 2024
Retirement Benefits [Abstract]
Retirement, Pension and Other Postretirement Plans	Retirement, pension and other postretirement plans Retirement plans — We have funded contributory retirement plans covering certain employees. Our contributions are primarily determined by the terms of the plans, subject to the limitation that they shall not exceed the amounts deductible for income tax purposes. We also sponsor unfunded contributory supplemental retirement plans for certain employees. Generally, benefits under these plans vest gradually over a period of approximately three years from date of employment and are based on the employee’s contribution. The expense applicable to retirement plans for 2024, 2023 and 2022 was approximately $30,564, $29,511 and $26,635, respectively. Pension plans — We have various pension plans covering a portion of our United States and international employees. Pension plan benefits are generally based on years of employment and, for salaried employees, the level of compensation. Actuarially determined amounts are contributed to United States plans to provide sufficient assets to meet future benefit payment requirements. We also sponsor an unfunded supplemental pension plan for certain employees. International subsidiaries fund their pension plans according to local requirements. During the second quarter of 2022, we completed a partial plan settlement transaction in regard to two of our U.S. pension plans in which plan assets amounting to $171,181 were used to purchase a group annuity contract from The Prudential Insurance Company of America ("Prudential"). The settlement resulted in a loss of $41,221, whic h is included in Pension settlement charge for U.S. Plans on the Consolidated Statements of Income. This transaction relieved the Company of its responsibility for the pension obligation related to certain retired employees and transferred the obligation and payment responsibility to Prudential for retirement benefits owed to approximately 1,500 retirees and other beneficiaries. The annuity contract covered retirees who commenced receiving benefits on or before November 1, 2021. The monthly retirement benefit payment amounts currently received by retirees and their beneficiaries did not change as a result of this transaction. Plan participants not included in the transaction remain in the plans and responsibility for payment of the retirement benefits remains with the Company. A reconciliation of the benefit obligations, plan assets, accrued benefit cost and the amount recognized in financial statements for pension plans is as follows: United States International 2024 2023 2024 2023 Change in benefit obligation: Benefit obligation at beginning of year $ 319,186 $ 303,520 $ 62,813 $ 60,880 Service cost 10,043 10,973 942 1,096 Interest cost 18,975 16,699 2,766 2,513 Participant contributions — — 82 79 Settlements (1,659) (1,499) (805) (607) Curtailments — — — (2) Foreign currency exchange rate change — — 2,320 3,566 Actuarial (gain) loss 30,709 (4,120) 4,086 (2,361) Benefits paid (8,906) (6,387) (2,841) (2,351) Benefit obligation at end of year $ 368,348 $ 319,186 $ 69,363 $ 62,813 Change in plan assets: Beginning fair value of plan assets $ 321,676 $ 333,851 $ 39,863 $ 38,316 Actual return on plan assets 52,744 (6,307) 4,460 117 Company contributions 2,187 2,018 2,104 2,429 Participant contributions — — 82 79 Settlements (1,659) (1,499) (805) (607) Foreign currency exchange rate change — — 1,966 1,880 Benefits paid (8,906) (6,387) (2,841) (2,351) Ending fair value of plan assets $ 366,042 $ 321,676 $ 44,829 $ 39,863 Funded status at end of year $ (2,306) $ 2,490 $ (24,534) $ (22,950) Amounts recognized in financial statements: Noncurrent asset $ 7,320 $ 11,473 $ 13,716 $ 9,991 Accrued benefit liability (977) (1,494) (6) (5) Long-term pension obligations (8,649) (7,489) (38,244) (32,936) Total amount recognized in financial statements $ (2,306) $ 2,490 $ (24,534) $ (22,950) The net actuarial loss included in the projected benefit obligation for the United States and international pension plans for 2024 was primarily due to lower discount rates partially offset by gains due to demographic experience. The actuarial gain included in the projected benefit obligation for the United States pension plans for 2023 was primarily due to higher discount rates partially offset by losses due to demographic experience. Amounts recognized in accumulated other comprehensive loss (income): United States International 2024 2023 2024 2023 Net actuarial loss (gain) $ 107,027 $ 102,506 $ (2,312) $ (3,122) Prior service cost (credit) — — (88) (91) Accumulated other comprehensive loss (income) $ 107,027 $ 102,506 $ (2,400) $ (3,213) The following table summarizes the changes in accumulated other comprehensive loss (income): United States International 2024 2023 2024 2023 Balance at beginning of year $ 102,506 $ 74,293 $ (3,213) $ (2,413) Net loss (gain) arising during the year 4,577 28,303 1,197 (943) Net (gain) recognized during the year — — (29) (79) Prior service adjustment recognized during the year — — 8 50 Settlement (gain) loss (56) (90) (95) 425 Curtailment (gain) loss — — — 2 Exchange rate effect during the year — — (268) (255) Balance at end of year $ 107,027 $ 102,506 $ (2,400) $ (3,213) Information regarding the funded status of the Company's plans is as follows: United States International 2024 2023 2024 2023 For plans with accumulated benefit obligation in excess of plan assets: Accumulated benefit obligation $ 10,121 $ 8,703 $ 41,647 $ 36,413 Fair value of plan assets — — 5,323 5,115 For plans with projected benefit obligation in excess of plan assets: Projected benefit obligation 9,626 8,983 43,574 38,039 Fair value of plan assets — — 5,323 5,115 Net periodic pension costs include the following components: United States International 2024 2023 2022 2024 2023 2022 Service cost $ 10,043 $ 10,973 $ 16,820 $ 942 $ 1,096 $ 1,693 Interest cost 18,975 16,699 14,486 2,766 2,513 1,105 Expected return on plan assets (26,611) (26,116) (27,776) (1,626) (1,532) (1,430) Amortization of prior service credit — — 48 (8) (50) (104) Amortization of net actuarial loss — — 7,504 29 79 2,278 Settlement loss (gain) 56 90 41,548 95 (425) (29) Curtailment gain — — — — (2) (2,112) Total benefit cost $ 2,463 $ 1,646 $ 52,630 $ 2,198 $ 1,679 $ 1,401 Net periodic pension cost for 2024 included a settlement loss of $151 due to lump sum retirement payments. Net periodic pension cost for 2023 included a settlement gain of $335 due to lump sum retirement payments. Net periodic pension cost for 2022 included a settlement loss of $298 due to lump sum retirement payments. Net periodic pension cost for 2022 included a curtailment gain of $2,112 due to the freeze of an international defined benefit plan. The components of net periodic pension cost other than service cost are included in Pension settlement charge for U.S. Plans and Other – net in our Consolidated Statements of Income The weighted average assumptions used in the valuation of pension benefits were as follows: United States International 2024 2023 2022 2024 2023 2022 Assumptions used to determine benefit obligations at October 31: Discount rate 5.27 % 6.08 % 5.70 % 3.80 % 4.35 % 3.78 % Rate of compensation increase 3.96 3.92 4.30 3.08 2.96 3.44 Assumptions used to determine net benefit costs for the years ended October 31: Discount rate - benefit obligation 6.08 5.70 3.02 4.35 3.78 1.30 Discount rate - service cost 6.18 5.89 3.42 3.48 2.88 1.14 Discount rate - interest cost 5.84 5.37 2.35 4.28 3.85 1.37 Expected return on plan assets 6.50 6.40 5.75 4.04 3.75 3.29 Rate of compensation increase 3.92 3.87 4.00 2.96 3.44 2.90 The amortization of prior service cost is determined using a straight-line amortization of the cost over the average remaining service period of employees expected to receive benefits under the plans. The discount rate reflects the current rate at which pension liabilities could be effectively settled at the end of the year. The discount rate used considers a yield derived from matching projected pension payments with maturities of a portfolio of available bonds that receive the highest rating given from a recognized investments ratings agency. The changes in the discount rates in 2024, 2023 and 2022 are due to changes in yields for these types of investments as a result of the economic environment. In determining the expected return on plan assets using the calculated value of plan assets, we consider both historical performance and an estimate of future long-term rates of return on assets similar to those in our plans. We consult with and consider the opinions of financial and other professionals in developing appropriate return assumptions. The rate of compensation increase is based on management’s estimates using historical experience and expected increases in rates. The international plans include a cash balance plan with promised interest crediting rates. The weighted average crediting rates were 1.10%, 0.70% and 0.60% for 2024, 2023 and 2022, respectively. Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when exceeding the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations. Gains or losses within the corridor remain in other comprehensive income and are retested in subsequent measurements. Gains or losses outside of the corridor are subject to amortization over an average employee future service period that differs by plan. If substantially all of the plan’s participants are no longer actively accruing benefits, the average life expectancy is used. The allocation of pension plan assets as of October 31, 2024 and 2023 is as follows: United States International 2024 2023 2024 2023 Asset Category Equity securities 3 % 3 % — % — % Debt securities 45 43 — — Insurance contracts — — 17 31 Pooled investment funds 51 53 82 67 Other 1 1 1 2 Total 100 % 100 % 100 % 100 % Our investment objective for defined benefit plan assets is to meet the plans’ benefit obligations, while minimizing the potential for future required plan contributions. Our United States plans comprise 89 percent of the Company's worldwide pension assets. In general, the investment strategies focus on asset class diversification, liquidity to meet benefit payments, and an appropriate balance of long-term investment return and risk. Target ranges for asset allocations are determined by dynamically matching the actuarial projections of the plans’ future liabilities and benefit payments with expected long-term rates of return on the assets, taking into account investment return volatility and correlations across asset classes. For 2024, the target in “return-seeking assets” is 30 percent and 70 percent in longer duration fixed income assets. Plan assets are diversified across multiple investment managers and are invested in liquid funds that are selected to track broad market indices. Investment risk is carefully controlled with plan assets rebalanced to target allocations on a periodic basis and continual monitoring of investment managers’ performance relative to the guidelines established with each investment manager. Our international plans comprise 11 percent of the Company's worldwide pension assets. Asset allocations are developed on a country-specific basis. Our investment strategy is to cover pension obligations with insurance contracts or to employ independent managers to invest the assets. The fair values of our pension plan assets at October 31, 2024 by asset category are in the table below: United States International Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash $ — $ — $ — $ — $ 442 $ 442 $ — $ — Equity securities: Basic materials 683 683 — — — — — — Consumer goods 1,788 1,788 — — — — — — Financial 2,461 2,461 — — — — — — Healthcare 1,811 1,811 — — — — — — Industrial goods 2,021 2,021 — — — — — — Technology 2,104 2,104 — — — — — — Fixed income securities: U.S. Government 58,000 — 58,000 — — — — — Corporate 100,909 — 100,909 — — — — — Other 5,879 — 5,879 — — — — — Other types of investments: Insurance contracts — — — — 7,390 — — 7,390 Other 1,524 1,524 — — — — — — Total investments in the fair value hierarchy $ 177,180 $ 12,392 $ 164,788 $ — $ 7,832 $ 442 $ — $ 7,390 Investments measured at Net Asset Value: Real estate collective funds 33,270 — Pooled investment funds 155,592 36,997 Total Investments at Fair Value $ 366,042 $ 44,829 The fair values of our pension plan assets at October 31, 2023 by asset category are in the table below: United States International Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash $ 355 $ 355 $ — $ — $ 777 $ 777 $ — $ — Money market funds 251 251 — — — — — — Equity securities: Basic materials 632 632 — — — — — — Consumer goods 1,614 1,614 — — — — — — Financial 1,787 1,787 — — — — — — Healthcare 1,368 1,368 — — — — — — Industrial goods 1,403 1,403 — — — — — — Technology 1,732 1,732 — — — — — — Fixed income securities: U.S. Government 42,269 — 42,269 — — — — — Corporate 94,650 — 94,650 — — — — — Other 2,640 — 2,640 — — — — — Other types of investments: Insurance contracts — — — — 12,224 — — 12,224 Other 2,092 2,092 — — — — — — Total investments in the fair value hierarchy $ 150,793 $ 11,234 $ 139,559 $ — $ 13,001 $ 777 $ — $ 12,224 Investments measured at Net Asset Value: Real estate collective funds 42,780 — Pooled investment funds 128,103 26,862 Total Investments at Fair Value $ 321,676 $ 39,863 These investment funds did not own a significant number of Nordson Corporation common shares for any year presented. The inputs and methodology used to measure fair value of plan assets are consistent with those described in Note 10. Following are the valuation methodologies used to measure these assets: • Money market funds - Money market funds are public investment vehicles that are valued with a net asset value of one dollar. This value is a quoted price in an active market and is classified as Level 1. • Equity securities - Common stocks and mutual funds are valued at the closing price reported on the active market on which the individual securities are traded and are classified as Level 1. • Fixed income securities - U.S. government securities are valued using bid evaluations and are classified as Level 2. Corporate fixed income securities are valued using evaluated prices, such as dealer quotes, bids and offers and are therefore classified as Level 2. • Insurance contracts - Insurance contracts are investments with various insurance companies. The contract value represents the best estimate of fair value. These contracts do not hold any specific assets. These investments are classified as Level 3. • Real estate collective funds – These funds are valued using the net asset value of the underlying properties. Net asset value is calculated using a combination of key inputs, such as revenue and expense growth rates, terminal capitalization rates and discount rates. • Pooled investment funds - These are public investment vehicles valued using the net asset value. The net asset value is based on the value of the assets owned by the plan, less liabilities. These investments are not quoted on an active exchange. The following tables present an analysis of changes during the years ended October 31, 2024 and 2023 in Level 3 plan assets, by plan asset class, for U.S. and international pension plans using significant unobservable inputs to measure fair value: Fair Value Measurements Insurance Beginning balance at October 31, 2023 $ 12,224 Actual return on plan assets: Purchases 1,428 Sales (7,010) Settlements (214) Unrealized gains 440 Foreign currency translation 522 Ending balance at October 31, 2024 $ 7,390 Fair Value Measurements Insurance Beginning balance at October 31, 2022 $ 18,066 Actual return on plan assets: Purchases 1,320 Sales (8,007) Settlements (607) Unrealized gains 266 Foreign currency translation 1,186 Ending balance at October 31, 2023 $ 12,224 Contributions to pension plans in 2025 are estimated to be approximately $3,726. Retiree pension benefit payments, which include expected future service, are anticipated to be paid as follows: Year United States International 2025 $ 10,851 $ 2,988 2026 $ 12,667 $ 5,076 2027 $ 14,587 $ 3,955 2028 $ 16,470 $ 3,637 2029 $ 18,297 $ 3,934 2030-2034 $ 117,167 $ 20,033 Other postretirement plans - We sponsor an unfunded postretirement health care benefit plan covering certain of our United States employees. Employees hired after January 1, 2002, are not eligible to participate in this plan. For eligible retirees under the age of 65 who enroll in the plan, the plan is contributory in nature, with retiree contributions in the form of premiums that are adjusted annually. For eligible retirees age 65 and older who enroll in the plan, the plan delivers a benefit in the form of a Health Reimbursement Account ("HRA"), which retirees use for eligible reimbursable expenses, including premiums paid for purchase of a Medicare supplement plan or other out-of-pocket medical expenses such as deductibles or co-pays. A reconciliation of the benefit obligations, accrued benefit cost and the amount recognized in financial statements for other postretirement plans in the United States is as follows: 2024 2023 Change in benefit obligation: Benefit obligation at beginning of year $ 53,433 $ 59,851 Service cost 281 399 Interest cost 3,018 3,063 Participant contributions 580 614 Actuarial (gain) loss 623 (7,301) Benefits paid (3,683) (3,193) Benefit obligation at end of year $ 54,252 $ 53,433 Change in plan assets: Beginning fair value of plan assets $ — $ — Company contributions 3,103 2,579 Participant contributions 580 614 Benefits paid (3,683) (3,193) Ending fair value of plan assets $ — $ — Funded status at end of year $ (54,252) $ (53,433) Amounts recognized in financial statements: Accrued benefit liability $ (2,890) $ (2,800) Long-term postretirement obligations (51,362) (50,633) Total amount recognized in financial statements $ (54,252) $ (53,433) The following table summarizes the changes in accumulated other comprehensive (gain) loss: 2024 2023 Balance at beginning of year $ (12,336) $ (5,035) Net (gain) loss arising during the year 623 (7,301) Net gain (loss) recognized during the year 591 — Balance at end of year $ (11,122) $ (12,336) Net postretirement benefit costs include the following components: 2024 2023 2022 Service cost $ 281 $ 399 $ 687 Interest cost 3,018 3,063 1,923 Amortization of net actuarial (gain) loss (591) — 978 Total benefit cost (credit) $ 2,708 $ 3,462 $ 3,588 The components of net postretirement benefit cost other than service cost are included in Other – net in our Consolidated Statements of Income. The weighted average assumptions used in the valuation of postretirement benefits were as follows: 2024 2023 2022 Assumptions used to determine benefit obligations at October 31: Discount rate 5.18 % 6.02 % 5.59 % Health care cost trend rate 2.25 3.40 3.50 Rate to which health care cost trend rate is assumed to incline/decline (ultimate trend rate) 1.80 3.16 3.19 Year the rate reaches the ultimate trend rate 2033 2032 2032 Assumption used to determine net benefit costs for the years ended October 31: Discount rate benefit obligation 6.02 % 5.59 % 2.98 % Discount rate service cost 6.26 6.00 3.55 Discount rate interest cost 5.76 5.22 2.30 The weighted average health care trend rates reflect expected increases in the Company’s portion of the obligation. The decrease in the health care cost trend rates in 2024 for the U.S. postretirement plan is due to a reduction in the long-term increase assumption for the HRA benefit. Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when exceeding the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations. Gains or losses outside of the corridor are subject to amortization over an average employee future service period that differs by plan. If substantially all of the plan’s participants are no longer actively accruing benefits, the average life expectancy is used. Contributions to postretirement plans in 2025 are estimated to be approximately $2,896. Retiree postretirement benefit payments are anticipated to be paid as follows: Year 2025 $ 2,890 2026 $ 3,021 2027 $ 3,203 2028 $ 3,331 2029 $ 3,455 2030-2034 $ 18,876

Income Taxes

Income Taxes	12 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income taxes Income before income taxes and income tax expense (benefit) are comprised of the following: 2024 2023 2022 Income before income taxes: Domestic $ 314,263 $ 269,934 $ 302,549 Foreign 271,218 345,405 346,730 Total income before income taxes $ 585,481 $ 615,339 $ 649,279 Current: U.S. federal $ 65,085 $ 54,157 $ 59,639 State and local 2,017 285 7,535 Foreign 69,652 89,520 79,734 Total current 136,754 143,962 146,908 Deferred: U.S. federal (11,622) (9,119) (9,408) State and local (1,387) (1,279) (596) Foreign (5,548) (5,718) (728) Total deferred (18,557) (16,116) (10,732) $ 118,197 $ 127,846 $ 136,176 A reconciliation of the U.S. statutory federal rate to the worldwide consolidated effective tax rate follows: 2024 2023 2022 Statutory federal income tax rate 21.00 % 21.00 % 21.00 % Share-based and other compensation (0.02) (0.25) 0.26 Foreign tax rate variances 1.22 1.83 0.95 State and local taxes, net of federal income tax benefit 0.08 (0.13) 0.84 Foreign-Derived Intangible Income Deduction (2.54) (2.24) (1.59) Global Intangible Low-Taxed Income net of foreign tax credits 0.40 0.71 0.23 Other – net 0.05 (0.14) (0.72) Effective tax rate 20.19 % 20.78 % 20.97 % Deferred income taxes are not provided on undistributed earnings of international subsidiaries that are intended to be permanently invested in their operations. These undistributed earnings represent the post-income tax earnings under U.S. GAAP not adjusted for previously taxed income which aggregated approximately $1,433,106 and $1,533,889 at October 31, 2024 and 2023, respectively. Should these earnings be distributed, applicable foreign tax credits, distributions of previously taxed income and utilization of other attributes would substantially offset taxes due upon the distribution. It is not practical to estimate the amount of additional taxes that might be payable on these basis differences because of the multiple methods by which these differences could reverse and the impact of withholding, U.S. state and local taxes and currency translation considerations. At October 31, 2024 and 2023, total unrecognized tax benefits were $7,481 and $8,002, respectively. The amounts that, if recognized, would impact the effective tax rate were $6,670 and $4,497 at October 31, 2024 and 2023, respectively. During 2024, unrecognized tax benefits related primarily to domestic positions and, as recognized, a substantial portion of the gross unrecognized tax benefits were offset against assets recorded in the Consolidated Balance Sheets. A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2024, 2023 and 2022 is as follows: 2024 2023 2022 Gross balance at beginning of year $ 8,002 $ 2,872 $ 3,720 Additions based on tax positions related to the current year 300 410 310 Additions for tax positions of prior years — 10 — Increases related to acquired businesses — 6,602 — Reductions for tax positions of prior years (418) — (70) Lapse of statute of limitations (403) (1,892) (1,088) Gross balance at end of year $ 7,481 $ 8,002 $ 2,872 At October 31, 2024 and 2023, we had accrued interest and penalty expense related to unrecognized tax benefits of $800 and $401, respectively. We include interest accrued related to unrecognized tax benefits in interest expense. Penalties, if incurred, would be recognized as other income (expense). We are subject to United States Federal income tax as well as income taxes in numerous state and foreign jurisdictions. We are subject to examination in the U.S. by the Internal Revenue Service ("IRS") for the years 2021 through 2024; years prior to 2021 year are closed to further examination by the IRS. Generally, major state and foreign jurisdiction tax years remain open to examination for years after 2018. Within the next twelve months, it is reasonably possible that certain statute of limitations periods would expire, which could result in a minimal decrease in our unrecognized tax benefits. Significant components of deferred tax assets and liabilities are as follows: 2024 2023 Deferred tax assets: Lease Liabilities $ 25,254 $ 26,678 Employee benefits 29,291 26,680 Tax credit and loss carryforwards 35,258 28,667 Other accruals not currently deductible for taxes 9,190 8,944 Inventory adjustments 16,634 5,932 Total deferred tax assets 115,627 96,901 Valuation allowance (33,596) (23,732) Total deferred tax assets 82,031 73,169 Deferred tax liabilities: Depreciation and amortization 256,183 238,210 Lease right-of-use assets 24,204 25,925 Other - net (3,865) 3,649 Total deferred tax liabilities 276,522 267,784 Net deferred tax liabilities $ (194,491) $ (194,615) At October 31, 2024, we had $20,367 of tax credit carryforwards, $15,116 of which expires in 2026-2038 and $5,251 of which has an indefinite carryforward period. We also had $30,897 of state operating loss carryforwards, $47,966 of foreign operating loss carryforwards, and a $4,459 capital loss carryforward, of which $58,426 will expire in 2025 through 2043, and $24,897 of which has an indefinite carryforward period. The net change in the valuation allowance was an increase of $9,864 in 2024 and an increase of $13,602 in 2023. The valuation allowance of $33,596 at October 31, 2024, related primarily to tax credits and loss carryforwards that may expire before being realized. We continue to assess the need for valuation allowances against deferred tax assets based on determinations of whether it is more likely than not that deferred tax benefits will be realized.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Long-Term Debt	Long-term debt A summary of long-term debt is as follows: 2024 2023 Notes Payable $ 18,285 $ 5,019 Revolving credit agreement, due 2028 240,000 248,000 Term loan, due 2026 280,000 300,000 Senior notes, due 2025 8,500 32,000 Senior notes, due 2025-2027 37,143 54,286 Senior notes, due 2025-2030 190,000 260,000 5.600% Notes due 2028 350,000 350,000 5.800% Notes due 2033 500,000 500,000 4.500% Notes due 2029 600,000 — 2,223,928 1,749,305 Less current maturities 103,928 115,662 Less unamortized debt issuance costs 16,359 10,773 Less bond discounts 2,444 1,476 Long-term maturities $ 2,101,197 $ 1,621,394 Revolving credit agreement — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our then existing syndicated revolving credit agreement. This facility had a five-year term expiring in April 2024 and included a $75,000 sub-facility for swing-line loans. On April 17, 2023, we entered into an amendment to, among other things, replace London Interbank Offered Rate with the Secured Overnight Financing Rate (“SOFR”), the Euro Interbank Offered Rate, the Sterling Overnight Index Average and the Tokyo Interbank Offered Rate for U.S. Dollar, Euro, British Pound Sterling and Japanese Yen borrowings, respectively. On June 6, 2023, this credit agreement was terminated and replaced by the New Credit Agreement (as defined below). In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). In June 2024, the Revolving Facility was amended to increase the aggregate principal amount to $922,500. The Company borrowed and has outstanding $280,000 on the Term Loan Facility and $240,000 on the Revolving Facility as of October 31, 2024 . The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) Risk-Free Rate ("RFR"), as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at October 31, 2024 was 5.66%. Senior notes, due 2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 0.73 years. The weighted-average interest rate at October 31, 2024 was 3.07 percent. Senior notes, due 2025-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 1.55 years. The weighted-average interest rate at October 31, 2024 was 3.13 percent. Senior notes, due 2025-2030 — These unsecured fixed-rate notes entered in 2018 with a group of insurance companies have a remaining weighted-average life of 2.70 years. The weighted-average interest rate at October 31, 2024 was 4.03 percent. 5.600% Notes due 2028 and 5.800% Notes due 2033 — In September 2023, we completed an underwritten public offering of $350,000 aggregate principal amount of 5.600% Notes due 2028 and $500,000 aggregate principal amount of 5.800% Notes due 2033. 4.500% Notes due 2029 - In September 2024, we completed an underwritten public offering of $600,000 aggregate principal amount of 4.500% Notes due 2029 (the "2029 Notes"). We were in compliance with all covenants at October 31, 2024 and the amount we could borrow would not have been limited by any debt covenants. Annual maturities — The annual ma turities of long-term debt for the five years subsequent to October 31, 2024, are as follows: $103,928 in 2025; $330,000 in 2026; $10,000 in 2027; $630,000 in 2028 and $620,000 in 2029. Bank lines of credit are summarized as follows: 2024 2023 Maximum borrowings available under bank lines of credit (all foreign banks) $ 123,983 $ 114,464 Outstanding borrowings / notes payable (all foreign bank debt) (18,285) (5,019) Unused bank lines of credit $ 105,698 $ 109,445

Leases

Leases	12 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Leases	Leases We review new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, we have recognized those amounts as part of the right-of-use assets and lease liabilities. We combine lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, we use an incremental borrowing rate ("IBR") based on information available at the lease commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. We calculate the IBR based on a bond yield curve which considers secured borrowing rates based on our credit rating and current economic environment, as well as other publicly available data. We lease certain manufacturing facilities, warehouse space, machinery and equipment, and vehicles. We often have options to renew lease terms for buildings and other assets. We evaluate renewal and termination options at the lease commencement date to determine if we are reasonably certain to exercise the option on the basis of economic factors. Leases with an initial term of 12 months or less (short-term leases) are not recorded on the Consolidated Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term, with variable lease payments recognized in the period those payments occur. Variable payments for leases primarily relate to future rates or amounts, miles, or other quantifiable usage factors which are not determinable at the time the lease agreement commences. Finance lease assets are recorded in Property, plant and equipment – net on the Consolidated Balance Sheets with related amortization recorded in depreciation expense on the Consolidated Statement of Cash Flows. As of October 31, 2024, we had no material leases that had yet to commence. Additional lease information is summarized below for the twelve months ended October 31: October 31, 2024 October 31, 2023 Finance Leases Operating Leases Finance Leases Operating Leases Amortization of right of use assets $ 5,978 $ 5,926 Interest 505 357 Lease cost (1) 6,483 $ 20,133 6,283 $ 19,662 Short-term and variable lease cost (1) 3,019 2,908 2,338 1,989 Total lease cost $ 9,502 $ 23,041 $ 8,621 $ 21,651 (1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Supplemental cash flow information is summarized below for the twelve months ended October 31, 2024: Finance Leases Operating Leases Cash outflows for leases $ 6,148 $ 20,754 Weighted average remaining lease term (years) 6.70 8.06 Weighted average discount rate 3.08% 2.09% The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the Consolidated Balance Sheet as of October 31, 2024. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2025 $ 5,713 $ 18,784 2026 4,316 17,651 2027 2,957 14,164 2028 1,385 11,379 2029 469 10,062 Later years 4,175 34,646 Total minimum lease payments 19,015 106,686 Amounts representing interest 1,670 8,805 Present value of minimum lease payments $ 17,345 $ 97,881 Rental expense for operating leases during the fiscal years ended October 31, 2024, 2023 and 2022 was $21,184, $22,095 and $20,479, respectively. Capitalized net finance leases included in property, plant and equipment during the fiscal years ended October 31, 2024 and October 31, 2023 was $16,364 and $16,310, respectively.
Leases	Leases We review new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, we have recognized those amounts as part of the right-of-use assets and lease liabilities. We combine lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, we use an incremental borrowing rate ("IBR") based on information available at the lease commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. We calculate the IBR based on a bond yield curve which considers secured borrowing rates based on our credit rating and current economic environment, as well as other publicly available data. We lease certain manufacturing facilities, warehouse space, machinery and equipment, and vehicles. We often have options to renew lease terms for buildings and other assets. We evaluate renewal and termination options at the lease commencement date to determine if we are reasonably certain to exercise the option on the basis of economic factors. Leases with an initial term of 12 months or less (short-term leases) are not recorded on the Consolidated Balance Sheets. Lease expense for operating leases is recognized on a straight-line basis over the lease term, with variable lease payments recognized in the period those payments occur. Variable payments for leases primarily relate to future rates or amounts, miles, or other quantifiable usage factors which are not determinable at the time the lease agreement commences. Finance lease assets are recorded in Property, plant and equipment – net on the Consolidated Balance Sheets with related amortization recorded in depreciation expense on the Consolidated Statement of Cash Flows. As of October 31, 2024, we had no material leases that had yet to commence. Additional lease information is summarized below for the twelve months ended October 31: October 31, 2024 October 31, 2023 Finance Leases Operating Leases Finance Leases Operating Leases Amortization of right of use assets $ 5,978 $ 5,926 Interest 505 357 Lease cost (1) 6,483 $ 20,133 6,283 $ 19,662 Short-term and variable lease cost (1) 3,019 2,908 2,338 1,989 Total lease cost $ 9,502 $ 23,041 $ 8,621 $ 21,651 (1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Supplemental cash flow information is summarized below for the twelve months ended October 31, 2024: Finance Leases Operating Leases Cash outflows for leases $ 6,148 $ 20,754 Weighted average remaining lease term (years) 6.70 8.06 Weighted average discount rate 3.08% 2.09% The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the Consolidated Balance Sheet as of October 31, 2024. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2025 $ 5,713 $ 18,784 2026 4,316 17,651 2027 2,957 14,164 2028 1,385 11,379 2029 469 10,062 Later years 4,175 34,646 Total minimum lease payments 19,015 106,686 Amounts representing interest 1,670 8,805 Present value of minimum lease payments $ 17,345 $ 97,881 Rental expense for operating leases during the fiscal years ended October 31, 2024, 2023 and 2022 was $21,184, $22,095 and $20,479, respectively. Capitalized net finance leases included in property, plant and equipment during the fiscal years ended October 31, 2024 and October 31, 2023 was $16,364 and $16,310, respectively.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair value measurements The inputs to the valuation techniques used to measure fair value are classified into the following categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: October 31, 2024 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 3,332 $ — $ 3,332 $ — Net investment contracts (b) 6,049 — 6,049 — Total assets at fair value $ 9,381 $ — $ 9,381 $ — Liabilities: Deferred compensation plans (c) $ 9,615 $ — $ 9,615 $ — Net investment contracts (b) 20,261 — 20,261 — Foreign currency forward contracts (a) 5,508 — 5,508 — Total liabilities at fair value $ 35,384 $ — $ 35,384 $ — October 31, 2023 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 696 $ — $ 696 $ — Net investment contracts (b) 13,713 — 13,713 — Total assets at fair value $ 14,409 $ — $ 14,409 $ — Liabilities: Deferred compensation plans (c) $ 9,637 $ — $ 9,637 $ — Net investment contracts (b) 9,985 — 9,985 — Foreign currency forward contracts (a) 10,425 — 10,425 — Total liabilities at fair value $ 30,047 $ — $ 30,047 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The fair value of these hedges is primarily based on the exchange rate between the currency pair of the hedge upon which settlement is based and includes an adjustment for the counterparty’s or Company’s credit risk. The notional amount of our net investment hedge contracts as of October 31, 2024 was $845,333. (c) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds. The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. 2024 2023 Carrying Fair Value Carrying Fair Value Long-term debt (including current portion) $ 2,186,840 $ 2,219,414 $ 1,732,037 $ 1,699,187 Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs and bond discounts as described in the Long-term debt Note.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Oct. 31, 2024
Investments, All Other Investments [Abstract]
Derivative Financial Instruments	Derivative financial instruments We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statement of Income together with the transaction gain or loss from the related balance sheet position. The settlement of these contracts is recorded in operating activities on the Consolidated Statement of Cash Flows. In 2024, we recognized net gains of $7,553 on foreign currency forward contracts and net loss of $13,052 from the change in fair value of balance sheet positions. In 2023, we recognized net losses of $3,041 on foreign currency forward contracts and net loss of $4,701 from the change in fair value of balance sheet positions. In 2022, we recognized net losses of $4,937 on foreign currency forward contracts and net gains of $11,207 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivables-net and Accrued liabilities, respectively in the Consolidated Balance Sheets. The following table summarizes, by currency, the contracts outstanding at October 31, 2024 and 2023: Notional Amounts Sell Buy October 31, 2024 contract amounts: Euro $ 156,836 $ 171,840 Pound sterling 22,043 168,763 Japanese yen 24,559 29,943 Mexican peso 1,732 27,996 Hong Kong dollar 1,946 1,961 Singapore dollar 73 21,472 Australian dollar — 10,167 Taiwan dollar — 8,000 Other 8,389 75,686 Total $ 215,578 $ 515,828 October 31, 2023 contract amounts: Euro $ 107,056 $ 53,919 Pound sterling 17,449 163,116 Japanese yen 18,858 22,088 Mexican peso 45 26,063 Hong Kong dollar 1,509 8,943 Singapore dollar 448 20,126 Australian dollar — 9,112 Taiwan Dollar — 8,000 Other 14,518 79,814 Total $ 159,883 $ 391,181 We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. As of October 31, 2024 and 2023, there were no significant concentrations of credit risk. Treasury Locks During the fourth quarter of 2024, the Company entered into treasury locks to fix the interest rate related to $250,000 of the $600,000 of 2029 Notes issued on September 4, 2024. The derivative positions were closed when the debt was priced on September 4, 2024 with a cash settlement net payment of $2,306 that offset changes in the benchmark treasury rate between execution of the treasury rate locks and the debt pricing date. These derivatives were designed as cash flow hedges and the deferred amount reported in AOCI is being reclassed to interest expense as payments are made on the notes through the maturity date. Net Investment Hedges Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. During 2024, the Company was party to various cross currency swaps between the U.S. Dollar and Euro, Japanese Yen, Taiwan Dollar, Singapore Dollar and Chinese Yuan, which were designated as hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheets until the sale or substantial liquidation of the underlying investments. A net gain of $16,214, net of tax of $5,366, was recorded in 2024 related to all net investment hedges, which is included in foreign currency translation adjustments in the Consolidated Statements of Shareholders' Equity. Changes in fair value of derivative instruments that do not qualify for hedge accounting are recognized immediately in current net earnings. The settlement of net investment hedges is recorded in investing activities on the Consolidated Statements of Cash Flows. The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheet as of October 31, 2024: Prepaid expenses and other current assets Other assets Accrued liabilities Other long-term liabilities Net investment contracts $ 5,976 $ 73 $ 10,675 $ 9,586

Capital Shares

Capital Shares	12 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Capital Shares	Capital shares Preferred — We have authorized 10,000 Series A convertible preferred shares without par value. No preferred shares were outstanding in 2024, 2023 or 2022. Common — We have 160,000 authorized common shares without par value. At October 31, 2024 and 2023, there were 98,023 common shares issued. At October 31, 2024 and 2023, the number of outstanding common shares, net of treasury shares, was 57,197 and 57,007, respectively. Common shares repurchased as part of publicly announced programs during 2024, 2023 and 2022 were as follows: Year Number Total Average 2024 123 $ 28,198 $ 228.60 2023 373 79,786 213.62 2022 1,190 260,288 218.69 These amounts exclude share repurchases associated with employee equity award exercises and vesting.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-based compensation During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the “2021 Plan”) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the "2012 Plan"). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that were available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of October 31, 2024, a total of 1,875 common shares were available to be granted under the 2021 Plan. Stock options — Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25 percent per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post-retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $4,616, $6,655 and $7,265 for 2024, 2023 and 2022, respectively. The following table summarizes activity related to stock options during 2024: Number of Weighted˗Average Aggregate Weighted˗Average Outstanding at October 31, 2023 1,062 $ 152.41 Granted 61 $ 238.35 Exercised (261) $ 121.80 Forfeited or expired (7) $ 229.54 Outstanding at October 31, 2024 855 $ 167.26 $ 70,409 4.7 years Expected to vest 164 $ 239.44 $ 2,110 7.8 years Exercisable at October 31, 2024 690 $ 149.97 $ 68,283 4.0 years Summarized information on currently outstanding options follows: Range of Exercise Price $67 - $125 $126 - $190 $191 - $268 Number outstanding 261 314 280 Weighted-average remaining contractual life, in years 3.0 4.5 7.4 Weighted-average exercise price $ 110.17 $ 154.44 $ 235.04 Number exercisable 261 313 116 Weighted-average exercise price $ 110.15 $ 154.36 $ 227.51 As of October 31, 2024, there was $4,981 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 2.8 years. The fair value of each option grant was estimated at the date of the grant using the Black-Scholes option-pricing model with the following assumptions: 2024 2023 2022 Expected volatility 30.3%-31.7% 30.4%-31.8% 30.6%-30.8% Expected dividend yield 1.15%-1.20% 1.12%-1.27% 0.76%-0.89% Risk-free interest rate 4.22%-4.52% 3.79%-4.21% 1.36%-2.65% Expected life of the option (in years) 5.0-6.2 5.0-6.2 5.3-6.2 The weighted-average expected volatility used to value options granted in 2024, 2023 and 2022 was 30.7 percent, 30.6 percent and 30.6 percent, respectively. Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of United States Treasury issues with terms equal to the expected life of the option being valued. The weighted average grant date fair value of stock options granted during 2024, 2023 and 2022 was $79.84, $77.99 and $78.88, respectively. The total intrinsic value of options exercised during 2024, 2023 and 2022 was $35,620, $23,706 and $15,376, respectively. Cash received from the exercise of stock options for 2024, 2023 and 2022 was $31,067, $21,373 and $12,124, respectively. Restricted shares and restricted share units — We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one . We may also grant continuation awards in the form of restricted share units with cliff vesting and a performance measure that must be achieved for the restricted share units to vest. For employee recipients, in the event of termination of employment due to early retirement, with consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units. For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units. As shares or units are issued, stock-based compensation equivalent to the fair market value on the date of grant is expensed over the vesting period. As of October 31, 2024, there was no unrecognized compensation cost related to restricted shares. The amount charged to expense related to restricted shares was $0, $336 and $1,096 in 2024, 2023 and 2022, respectively. These amounts included common share dividends of $0, $5 and $19 in 2024, 2023 and 2022, respectively. The following table summarizes activity related to restricted share units in 2024: Number of Weighted˗Average Grant Date Fair Restricted share units at October 31, 2023 69 $ 236.28 Granted 41 $ 235.53 Forfeited (6) $ 241.89 Vested (37) $ 229.72 Restricted share units at October 31, 2024 67 $ 238.83 As of October 31, 2024, there was $8,883 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.8 years. The amounts charged to expense related to restricted share units in 2024, 2023 and 2022 were $8,853, $8,765 and $8,403, respectively. Restricted share unit expense increased beginning in 2021 compared to prior years as the granting of restricted share units has generally replaced the granting of stock options for key employees. Performance share incentive awards — Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved . The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards with market conditions. The per share values were $229.58 and $225.14 for 2024; $231.34, $211.25 and $214.51 for 2023; and $260.60, $273.50 and $221.94 for 2022. The amount charged to expense for executive officers and selected other key employees in 2024, 2023 and 2022 were $5,070, $6,543 and $13,626, respectively. As of October 31, 2024, there was $6,529 of unrecognized compensation cost related to performance share incentive awards. Deferred compensation — Our executive officers and other highly compensated employees may elect to defer up to 100 percent of their base pay and cash incentive compensation and, for executive officers, up to 90 percent of their share-based performance incentive award payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan was $97, $107 and $72 for 2024, 2023 and 2022, respectively . Deferred directors’ compensation — Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared. The following table summarizes activity related to director deferred compensation share equivalent units during 2024: Number of Weighted˗Average Outstanding at October 31, 2023 78 $ 93.11 Restricted stock units vested 5 $ 215.81 Dividend equivalents 1 $ 249.07 Distributions (19) $ 54.54 Outstanding at October 31, 2024 65 $ 115.66 The amount charged to expense related to director deferred compensation was $321, $309 and $305 in 2024, 2023 and 2022, respectively. Shares reserved for future issuance — At October 31, 2024, there were 1,139 of common shares reserved for future issuance through the exercise of outstanding options or rights .

Operating Segments and Geograph

Operating Segments and Geographic Area Data	12 Months Ended
	Oct. 31, 2024
Segment Reporting [Abstract]
Operating Segments and Geographic Area Data	Operating segments and geographic area data We conduct business in three primary operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Consolidated Statement of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in Note 1. Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispense and measurement and control, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, agricultural, consumer durables and non-durables markets. Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes. Advanced Technology Solutions: This segment focuses on products serving electronics end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics. No single customer accounted for 10 percent or more of sales in 2024, 2023 or 2022. The following table presents information about our reportable segments: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Solutions Corporate Total Year ended October 31, 2024 Net external sales $ 1,484,249 $ 695,452 $ 510,220 $ — $ 2,689,921 Depreciation and amortization 56,856 58,061 13,433 7,825 136,175 Operating profit (loss) 470,559 187,731 94,231 (78,520) 674,001 Identifiable assets (a) 1,926,426 2,267,239 697,224 1,184,222 6,075,111 Property, plant and equipment expenditures 16,892 19,533 4,269 23,716 64,410 Year ended October 31, 2023 Net external sales $ 1,391,046 $ 660,316 $ 577,270 $ — $ 2,628,632 Depreciation and amortization 33,228 54,988 15,185 8,497 111,898 Operating profit (loss) 460,889 189,367 101,662 (79,157) 672,761 Identifiable assets (a) 1,932,527 1,544,456 730,192 1,105,471 5,312,646 Property, plant and equipment expenditures 9,257 15,716 4,209 5,401 34,583 Year ended October 31, 2022 Net external sales $ 1,337,242 $ 690,177 $ 562,859 $ — $ 2,590,278 Depreciation and amortization 27,891 54,674 8,780 8,578 99,923 Operating profit (loss) 434,476 217,199 133,253 (82,568) 702,360 Identifiable assets (a) 1,112,825 1,558,861 397,250 812,964 3,881,900 Property, plant and equipment expenditures 9,490 31,009 2,383 8,546 51,428 (a) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets. We have significant sales and long-lived assets in the following geographic areas: 2024 2023 2022 Net external sales Americas $ 1,178,626 $ 1,149,760 $ 1,096,596 Europe 726,100 682,676 645,603 Asia Pacific 785,195 796,196 848,079 Total net external sales $ 2,689,921 $ 2,628,632 $ 2,590,278 Long-lived assets Americas $ 465,521 $ 328,312 $ 332,709 Europe 113,274 109,428 62,039 Asia Pacific 59,432 61,282 60,973 Total long-lived assets $ 638,227 $ 499,022 $ 455,721 Long-lived assets include property, plant and equipment - net and operating right of use lease assets. A reconciliation of total assets for reportable segments to total consolidated assets is as follows: 2024 2023 2022 Total identifiable assets for reportable segments $ 6,075,111 $ 5,312,646 $ 3,881,900 Eliminations (74,145) (60,876) (61,525) Total consolidated assets $ 6,000,966 $ 5,251,770 $ 3,820,375

Supplemental Information for th

Supplemental Information for the Statement of Cash Flows	12 Months Ended
	Oct. 31, 2024
Cash and Cash Equivalents [Abstract]
Supplemental Information for the Statement of Cash Flows	Supplemental information for the statement of cash flows 2024 2023 2022 Cash operating activities: Interest paid $ 85,966 $ 54,710 $ 22,975 Income taxes paid 160,122 112,912 141,212

Contingencies

Contingencies	12 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. Including the environmental matter discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows. We have voluntarily agreed with the City of New Richmond, Wisconsin and other Potentially Responsible Parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the “Site”) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. At October 31, 2024 and October 31, 2023, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was $181 and $231, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts and Reserves	12 Months Ended
	Oct. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts and Reserves	Schedule II – Valuation and Qualifying Accounts and Reserves Balance at Charged to Additions (Deductions) Currency Balance Allowance for Doubtful Accounts 2022 $ 7,552 1,259 (1,336) 743 $ 8,218 2023 $ 8,218 283 1,469 45 $ 10,015 2024 $ 10,015 619 (347) (518) $ 9,769 Inventory Obsolescence and Other Reserves 2022 $ 45,863 18,694 (18,372) (450) $ 45,735 2023 $ 45,735 24,925 6,617 (152) $ 77,125 2024 $ 77,125 28,563 (20,063) 172 $ 85,797

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net income	$ 467,284	$ 487,493	$ 513,103

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 31, 2024
Consolidation	Consolidation — The consolidated financial statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50 percent or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of estimates — The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and notes. Actual amounts could differ from these estimates.
Fiscal Year	Fiscal year — Our fiscal year is November 1 through October 31.
Revenue Recognition	Revenue recognition — A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. For products in which control transfers upon delivery, revenue is deferred for undelivered items and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of October 31, 2024 and 2023 were not material. However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled, and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at October 31, 2024 or 2023. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues for October 31, 2024 and 2023. Revenue is measured as the amount of consideration we expect to be entitled to in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs, as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred, as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Consolidated Statements of Income. We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and is not material. Certain arrangements may include installation, installation supervision, training and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, therefore, these items are typically regarded as inconsequential or not material.
Advertising Costs	Advertising costs — Advertising costs are expensed as incurred and we re $8,923, $7,635 and $7,028 in 2024, 2023 and 2022, respectively.
Research and Development	Research and development — Investments in research and development are important to our long-term growth, enabling us to keep pace with changing customer and marketplace needs through the development of new products and new applications for existing products. We place strong emphasis on technology developments and improvements through internal engineering and research teams. Research and development costs are expensed as incurred and were $64,992
Earnings Per Share	Earnings per share — Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted stock and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options f or 74 c ommon shares were excluded from the diluted earnings per share calculation in 2024 and 140 and 78 options were excluded from the calculation of diluted earnings per share in 2023 and 2022, respectively, because their effect would have been anti-dilutive. Under the 2021 Stock Incentive and Award Plan, executive officers and selected other key employees receive common share awards based on corporate performance measures over three-year performance periods. Awards for which performance measures have not been met were excluded from the calculation of diluted earnings per share.
Cash and cash equivalents	Cash and cash equivalents — Highly liquid instruments with maturities of 90 days or less at date of purchase are considered to be cash equivalents.
Allowance for Doubtful Accounts	Allowance for doubtful accounts — An allowance for doubtful accounts is maintained for estimated losses resulting from the inability of customers to make required payments. The amount of the allowance is determined principally on the basis of past collection experience and known factors regarding specific customers. Accounts are written off against the allowance when it becomes evident that collection will not occur. Credit is extended to customers satisfying pre-defined credit criteria. We believe we have limited concentration of credit risk due to the diversity of our customer base. Our primary allowance for credit losses is the allowance for doubtful accounts, which is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible.
Inventories	Inventories
Derivatives	Derivatives — The Company does not enter into derivative financial instruments for trading purposes. Derivative instruments are used to manage risks associated with foreign exchange rates. We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. The settlement of these contracts is recorded in operating activities on the Consolidated Statements of Cash Flows. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. These hedges are included on the balance sheet at fair value. Changes in the fair value of derivative assets or liabilities (i.e., gains or losses) are recognized depending upon the type of hedging relationship and whether a hedge has been designated. For derivative instruments that qualify for hedge accounting and are used to hedge net assets of certain foreign subsidiaries, we designate the hedging instrument as a hedge of a net investment in a foreign operation with the effective portion of the derivative's gain or loss reported in Accumulated other comprehensive loss as part of the cumulative translation adjustment and amounts reclassified out of accumulated other comprehensive loss into earnings when the hedged net investment is either sold or substantially liquidated. The settlement of these hedges is recorded in investing activities on the Consolidated Statement of Cash Flows. Changes in fair value of derivative instruments that do not qualify for hedge accounting are recognized immediately in current net earnings in "Other-net" on the Consolidated Statements of Income. The Company has entered into treasury locks to fix the interest rate related to notes issued. The derivative positions are closed when the debt is priced with a cash settlement net payment that offsets changes in the benchmark treasury rate between execution of the treasury rate locks and the debt pricing date. The treasury locks are designed as cash flow hedges and the deferred amounts are reported in Accumulated Other Comprehensive Income (loss) ("AOCI") and subsequently reclassed to interest expense as payments are made on the notes through the maturity date.
Property, Plant and Equipment and Depreciation	Property, plant and equipment and depreciation — Property, plant and equipment are carried at cost. Additions and improvements that extend the lives of assets are capitalized, while expenditures for repairs and maintenance are expensed as incurred. Plant and equipment are depreciated for financial reporting purposes using the straight-line method over the estimated useful lives of the assets or, in the case of property under finance leases, over the terms of the leases. Leasehold improvements are depreciated over the shorter of the lease term or their useful lives. Useful lives are as follows: Land improvements 15-25 years Buildings 20-40 years Machinery and equipment 3-18 years Enterprise management systems 5-13 years Depreciation expense is included in Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Internal use software costs are expensed or capitalized depending on whether they are incurred in the preliminary project stage, application development stage or the post-implementation stage. Amounts capitalized are amortized over the estimated useful lives of the software beginning with the project’s completion. All re-engineering costs are expensed as incurred. Interest costs on significant capital projects are capitalized. No interest was capitalized in 2024, 2023 or 2022.
Goodwill and Intangible Assets	Goodwill and intangible assets — Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill relates to and is assigned directly to specific reporting units. Goodwill is not amortized but is subject to annual impairment testing. Our annual impairment testing is performed as of August 1. Testing is done more frequently if an event occurs or circumstances change that would indicate the fair value of a reporting unit is less than the carrying amount of those assets. The acquisitions of our businesses are accounted for under the acquisition method of accounting. The amounts assigned to the identifiable assets acquired and liabilities assumed in connection with acquisitions are based on estimated fair values as of the date of the acquisition, with the remainder, if any, recorded as goodwill. The fair values are determined by management, taking into consideration information supplied by the management of the acquired entities, and other relevant information. Such information typically includes valuations obtained from independent appraisal experts, which management reviews and considers in its estimates of fair values. The valuations are generally based upon future cash flow projections for the acquired assets, discounted to present value. Determining the fair value of assets acquired and liabilities assumed requires management’s judgment and often involves the use of significant estimates and assumptions, including assumptions with respect to future revenue growth rates and EBITDA margins, discount rates, customer attrition rates, and asset lives, among other items. This judgment could result in either a higher or lower value assigned to amortizable or depreciable assets. The impact could result in either higher or lower amortization and/or depreciation expense. Other amortizable intangible assets, which consist primarily of patent/technology costs, customer relationships, non-compete agreements and trade names, are amortized over their useful lives on a straight-line basis. At October 31, 2024, the weighted-average useful lives for each major category of amortizable intangible assets were: Patent/technology costs 11 years Customer relationships 17 years Noncompete agreements 4 years Trade names 10 years
Foreign Currency Translation	Foreign currency translation — The financial statements of subsidiaries outside the United States are generally measured using the local currency as the functional currency. Assets and liabilities of these subsidiaries are translated at the rates of exchange at the balance sheet dates. Income and expense items are translated at average monthly rates of exchange. The resulting translation adjustments are included in AOCI, a separate component of Shareholders’ equity. Generally, gains and losses from foreign currency transactions, including forward contracts, of these subsidiaries and the United States parent are included in net income. Gains and losses from intercompany foreign currency transactions of a long-term investment nature are included in AOCI.
Warranties	Warranties — We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) measured from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets. Following is a reconciliation of the product warranty liability as of October 31, 2024 and 2023: 2024 2023 Balance at beginning of year $ 14,401 $ 11,723 Accruals for warranties 14,965 20,910 Warranty payments (15,717) (16,171) Currency adjustments (111) (2,061) Balance at end of year $ 13,538 $ 14,401
Shipping and Handling Costs
Shipping and Handling Costs	Shipping and handling costs — Amounts billed to customers for shipping and handling are recorded as revenue. Shipping and handling expenses are included in cost of sales.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Useful Lives of Property, Plant and Equipment and Depreciation	Useful lives are as follows: Land improvements 15-25 years Buildings 20-40 years Machinery and equipment 3-18 years Enterprise management systems 5-13 years
Weighted Average Useful Lives for Each Major Category of Amortizable Intangible Assets	At October 31, 2024, the weighted-average useful lives for each major category of amortizable intangible assets were: Patent/technology costs 11 years Customer relationships 17 years Noncompete agreements 4 years Trade names 10 years
Summary of Accumulated Other Comprehensive Loss	Accumulated other comprehensive loss at October 31, 2024 and 2023 consisted of: Cumulative Pension and Accumulated Balance at October 31, 2023 $ (133,280) $ (63,161) $ (196,441) Pension and postretirement plan changes, net of tax of $1,716 — (4,789) (4,789) Currency translation losses 16,390 — 16,390 Balance at October 31, 2024 $ (116,890) $ (67,950) $ (184,840)
Reconciliation of Product Warranty Liability	Following is a reconciliation of the product warranty liability as of October 31, 2024 and 2023: 2024 2023 Balance at beginning of year $ 14,401 $ 11,723 Accruals for warranties 14,965 20,910 Warranty payments (15,717) (16,171) Currency adjustments (111) (2,061) Balance at end of year $ 13,538 $ 14,401

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Oct. 31, 2024
Atrion Corporation
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assets and liabilities acquired were as follows: August 21, 2024 Cash $ 24,428 Receivables - net 20,883 Inventories - net 64,801 Goodwill 494,279 Intangibles 129,600 Other assets 158,059 Total Assets $ 892,050 Accounts payable $ 25,587 Deferred income taxes 31,221 Other liabilities 20,818 Total Liabilities $ 77,626
ARAG Group
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assets and liabilities acquired were as follows: August 24, 2023 Cash $ 32,966 Receivables - net 31,081 Inventories - net 54,252 Goodwill 684,938 Intangibles 353,500 Other assets 55,963 Total Assets $ 1,212,700 Accounts payable $ 18,915 Deferred income taxes 100,097 Other liabilities 15,785 Total Liabilities $ 134,797
CyberOptics Corporation
Business Acquisition [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assets and liabilities acquired were as follows: November 3, 2022 Cash $ 40,890 Receivables - net 21,364 Inventories - net 33,639 Goodwill 285,330 Intangibles 58,600 Other assets 13,768 Total Assets $ 453,591 Accounts payable $ 8,109 Deferred income taxes 14,826 Other liabilities 11,923 Total Liabilities $ 34,858

Details of Consolidated Balan_2

Details of Consolidated Balance Sheet (Tables)	12 Months Ended
	Oct. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Details of Consolidated Balance Sheet	Note 4 — Details of Consolidated Balance Sheet 2024 2023 Receivables: Accounts $ 571,381 $ 558,393 Notes 595 662 Other 32,456 41,845 604,432 600,901 Allowance for doubtful accounts (9,769) (10,015) $ 594,663 $ 590,886 Inventories: Finished goods $ 256,465 $ 233,552 Raw materials and component parts 250,477 211,874 Work-in-process 55,790 86,474 562,732 531,900 Obsolescence and other reserves (85,797) (77,125) $ 476,935 $ 454,775 Property, plant and equipment: Land $ 32,018 $ 15,792 Land improvements 4,822 5,019 Buildings 354,854 294,267 Machinery and equipment 649,510 549,291 Enterprise management system 53,401 52,939 Construction-in-progress 58,362 24,916 Leased property under finance leases 29,404 28,406 1,182,371 970,630 Accumulated depreciation (637,764) (577,784) $ 544,607 $ 392,846 Accrued liabilities: Salaries and other compensation $ 77,799 $ 63,130 Interest 13,800 11,240 Taxes other than income taxes 13,560 14,894 Warranty 13,538 14,401 Net Investment Contracts 10,675 — Pension and other employee benefits 8,919 8,686 Commissions and rebates 6,844 8,823 Foreign currency forward contracts 5,508 10,425 Other 74,588 67,989 $ 225,231 $ 199,588

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amount of Goodwill	Changes in the carrying amount of goodwill during 2024 by operating segment: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Systems Total Balance at October 31, 2023 $ 1,208,996 $ 1,173,858 $ 401,347 $ 2,784,201 Acquisitions (9,962) 494,279 — 484,317 Currency effect 8,597 1,611 2,093 12,301 Balance at October 31, 2024 $ 1,207,631 $ 1,669,748 $ 403,440 $ 3,280,819 The increase in goodwill for 2024 was due to the acquisition of Atrion. See Note 3 to the Consolidated Financial Statements for additional details. Changes in the carrying amount of goodwill during 2023 by operating segment: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Systems Total Balance at October 31, 2022 $ 520,236 $ 1,172,069 $ 112,388 $ 1,804,693 Acquisitions 694,900 — 285,330 980,230 Currency effect (6,140) 1,789 3,629 (722) Balance at October 31, 2023 $ 1,208,996 $ 1,173,858 $ 401,347 $ 2,784,201
Summary of Intangible Assets Subject to Amortization	Information regarding intangible assets subject to amortization: October 31, 2024 Carrying Accumulated Net Book Customer relationships $ 878,071 $ 339,756 $ 538,315 Patent/technology costs 232,371 134,187 98,184 Trade names 167,144 62,887 104,257 Noncompete agreements 8,502 8,412 90 Other 500 500 — Total $ 1,286,588 $ 545,742 $ 740,846 October 31, 2023 Carrying Accumulated Net Book Customer relationships $ 794,706 $ 287,585 $ 507,121 Patent/technology costs 204,905 112,994 91,911 Trade names 125,692 52,488 73,204 Noncompete agreements 10,028 9,521 507 Other 182 181 1 Total $ 1,135,513 $ 462,769 $ 672,744
Estimated Amortization Expense	Estimated amortization expense for each of the five succeeding years: Year Amounts 2025 $ 77,220 2026 $ 73,639 2027 $ 70,807 2028 $ 68,239 2029 $ 62,334

Retirement, Pension and Other_2

Retirement, Pension and Other Postretirement Plans (Tables)	12 Months Ended
	Oct. 31, 2024
Summary of Accumulated Other Comprehensive Loss	Accumulated other comprehensive loss at October 31, 2024 and 2023 consisted of: Cumulative Pension and Accumulated Balance at October 31, 2023 $ (133,280) $ (63,161) $ (196,441) Pension and postretirement plan changes, net of tax of $1,716 — (4,789) (4,789) Currency translation losses 16,390 — 16,390 Balance at October 31, 2024 $ (116,890) $ (67,950) $ (184,840)
Pension Plans
Reconciliation of the Benefit Obligations, Plan Assets, Accrued Benefit Cost and the Amount Recognized in Financial Statements for Pension Plans	A reconciliation of the benefit obligations, plan assets, accrued benefit cost and the amount recognized in financial statements for pension plans is as follows: United States International 2024 2023 2024 2023 Change in benefit obligation: Benefit obligation at beginning of year $ 319,186 $ 303,520 $ 62,813 $ 60,880 Service cost 10,043 10,973 942 1,096 Interest cost 18,975 16,699 2,766 2,513 Participant contributions — — 82 79 Settlements (1,659) (1,499) (805) (607) Curtailments — — — (2) Foreign currency exchange rate change — — 2,320 3,566 Actuarial (gain) loss 30,709 (4,120) 4,086 (2,361) Benefits paid (8,906) (6,387) (2,841) (2,351) Benefit obligation at end of year $ 368,348 $ 319,186 $ 69,363 $ 62,813 Change in plan assets: Beginning fair value of plan assets $ 321,676 $ 333,851 $ 39,863 $ 38,316 Actual return on plan assets 52,744 (6,307) 4,460 117 Company contributions 2,187 2,018 2,104 2,429 Participant contributions — — 82 79 Settlements (1,659) (1,499) (805) (607) Foreign currency exchange rate change — — 1,966 1,880 Benefits paid (8,906) (6,387) (2,841) (2,351) Ending fair value of plan assets $ 366,042 $ 321,676 $ 44,829 $ 39,863 Funded status at end of year $ (2,306) $ 2,490 $ (24,534) $ (22,950) Amounts recognized in financial statements: Noncurrent asset $ 7,320 $ 11,473 $ 13,716 $ 9,991 Accrued benefit liability (977) (1,494) (6) (5) Long-term pension obligations (8,649) (7,489) (38,244) (32,936) Total amount recognized in financial statements $ (2,306) $ 2,490 $ (24,534) $ (22,950) The net actuarial loss included in the projected benefit obligation for the United States and international pension plans for 2024 was primarily due to lower discount rates partially offset by gains due to demographic experience. The actuarial gain included in the projected benefit obligation for the United States pension plans for 2023 was primarily due to higher discount rates partially offset by losses due to demographic experience. Amounts recognized in accumulated other comprehensive loss (income): United States International 2024 2023 2024 2023 Net actuarial loss (gain) $ 107,027 $ 102,506 $ (2,312) $ (3,122) Prior service cost (credit) — — (88) (91) Accumulated other comprehensive loss (income) $ 107,027 $ 102,506 $ (2,400) $ (3,213)
Summary of Accumulated Other Comprehensive Loss	The following table summarizes the changes in accumulated other comprehensive loss (income): United States International 2024 2023 2024 2023 Balance at beginning of year $ 102,506 $ 74,293 $ (3,213) $ (2,413) Net loss (gain) arising during the year 4,577 28,303 1,197 (943) Net (gain) recognized during the year — — (29) (79) Prior service adjustment recognized during the year — — 8 50 Settlement (gain) loss (56) (90) (95) 425 Curtailment (gain) loss — — — 2 Exchange rate effect during the year — — (268) (255) Balance at end of year $ 107,027 $ 102,506 $ (2,400) $ (3,213)
Accumulated Benefit Obligation	Information regarding the funded status of the Company's plans is as follows: United States International 2024 2023 2024 2023 For plans with accumulated benefit obligation in excess of plan assets: Accumulated benefit obligation $ 10,121 $ 8,703 $ 41,647 $ 36,413 Fair value of plan assets — — 5,323 5,115 For plans with projected benefit obligation in excess of plan assets: Projected benefit obligation 9,626 8,983 43,574 38,039 Fair value of plan assets — — 5,323 5,115
Components of Net Periodic Benefits Cost	Net periodic pension costs include the following components: United States International 2024 2023 2022 2024 2023 2022 Service cost $ 10,043 $ 10,973 $ 16,820 $ 942 $ 1,096 $ 1,693 Interest cost 18,975 16,699 14,486 2,766 2,513 1,105 Expected return on plan assets (26,611) (26,116) (27,776) (1,626) (1,532) (1,430) Amortization of prior service credit — — 48 (8) (50) (104) Amortization of net actuarial loss — — 7,504 29 79 2,278 Settlement loss (gain) 56 90 41,548 95 (425) (29) Curtailment gain — — — — (2) (2,112) Total benefit cost $ 2,463 $ 1,646 $ 52,630 $ 2,198 $ 1,679 $ 1,401
Weighted Average Assumptions Representing the Rates Used to Develop the Actuarial Present Value of Projected Benefit Obligation and the Net Periodic Benefit Costs	The weighted average assumptions used in the valuation of pension benefits were as follows: United States International 2024 2023 2022 2024 2023 2022 Assumptions used to determine benefit obligations at October 31: Discount rate 5.27 % 6.08 % 5.70 % 3.80 % 4.35 % 3.78 % Rate of compensation increase 3.96 3.92 4.30 3.08 2.96 3.44 Assumptions used to determine net benefit costs for the years ended October 31: Discount rate - benefit obligation 6.08 5.70 3.02 4.35 3.78 1.30 Discount rate - service cost 6.18 5.89 3.42 3.48 2.88 1.14 Discount rate - interest cost 5.84 5.37 2.35 4.28 3.85 1.37 Expected return on plan assets 6.50 6.40 5.75 4.04 3.75 3.29 Rate of compensation increase 3.92 3.87 4.00 2.96 3.44 2.90
Allocation of Pension Plan Assets	The allocation of pension plan assets as of October 31, 2024 and 2023 is as follows: United States International 2024 2023 2024 2023 Asset Category Equity securities 3 % 3 % — % — % Debt securities 45 43 — — Insurance contracts — — 17 31 Pooled investment funds 51 53 82 67 Other 1 1 1 2 Total 100 % 100 % 100 % 100 %
Fair Values of Pension Plan Assets	The fair values of our pension plan assets at October 31, 2024 by asset category are in the table below: United States International Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash $ — $ — $ — $ — $ 442 $ 442 $ — $ — Equity securities: Basic materials 683 683 — — — — — — Consumer goods 1,788 1,788 — — — — — — Financial 2,461 2,461 — — — — — — Healthcare 1,811 1,811 — — — — — — Industrial goods 2,021 2,021 — — — — — — Technology 2,104 2,104 — — — — — — Fixed income securities: U.S. Government 58,000 — 58,000 — — — — — Corporate 100,909 — 100,909 — — — — — Other 5,879 — 5,879 — — — — — Other types of investments: Insurance contracts — — — — 7,390 — — 7,390 Other 1,524 1,524 — — — — — — Total investments in the fair value hierarchy $ 177,180 $ 12,392 $ 164,788 $ — $ 7,832 $ 442 $ — $ 7,390 Investments measured at Net Asset Value: Real estate collective funds 33,270 — Pooled investment funds 155,592 36,997 Total Investments at Fair Value $ 366,042 $ 44,829 The fair values of our pension plan assets at October 31, 2023 by asset category are in the table below: United States International Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash $ 355 $ 355 $ — $ — $ 777 $ 777 $ — $ — Money market funds 251 251 — — — — — — Equity securities: Basic materials 632 632 — — — — — — Consumer goods 1,614 1,614 — — — — — — Financial 1,787 1,787 — — — — — — Healthcare 1,368 1,368 — — — — — — Industrial goods 1,403 1,403 — — — — — — Technology 1,732 1,732 — — — — — — Fixed income securities: U.S. Government 42,269 — 42,269 — — — — — Corporate 94,650 — 94,650 — — — — — Other 2,640 — 2,640 — — — — — Other types of investments: Insurance contracts — — — — 12,224 — — 12,224 Other 2,092 2,092 — — — — — — Total investments in the fair value hierarchy $ 150,793 $ 11,234 $ 139,559 $ — $ 13,001 $ 777 $ — $ 12,224 Investments measured at Net Asset Value: Real estate collective funds 42,780 — Pooled investment funds 128,103 26,862 Total Investments at Fair Value $ 321,676 $ 39,863
Change in Level 3 Fair Value of Plan Assets	The following tables present an analysis of changes during the years ended October 31, 2024 and 2023 in Level 3 plan assets, by plan asset class, for U.S. and international pension plans using significant unobservable inputs to measure fair value: Fair Value Measurements Insurance Beginning balance at October 31, 2023 $ 12,224 Actual return on plan assets: Purchases 1,428 Sales (7,010) Settlements (214) Unrealized gains 440 Foreign currency translation 522 Ending balance at October 31, 2024 $ 7,390 Fair Value Measurements Insurance Beginning balance at October 31, 2022 $ 18,066 Actual return on plan assets: Purchases 1,320 Sales (8,007) Settlements (607) Unrealized gains 266 Foreign currency translation 1,186 Ending balance at October 31, 2023 $ 12,224
Retiree Pension Benefit Payments	Retiree pension benefit payments, which include expected future service, are anticipated to be paid as follows: Year United States International 2025 $ 10,851 $ 2,988 2026 $ 12,667 $ 5,076 2027 $ 14,587 $ 3,955 2028 $ 16,470 $ 3,637 2029 $ 18,297 $ 3,934 2030-2034 $ 117,167 $ 20,033
Retirement Plans
Reconciliation of the Benefit Obligations, Plan Assets, Accrued Benefit Cost and the Amount Recognized in Financial Statements for Pension Plans	A reconciliation of the benefit obligations, accrued benefit cost and the amount recognized in financial statements for other postretirement plans in the United States is as follows: 2024 2023 Change in benefit obligation: Benefit obligation at beginning of year $ 53,433 $ 59,851 Service cost 281 399 Interest cost 3,018 3,063 Participant contributions 580 614 Actuarial (gain) loss 623 (7,301) Benefits paid (3,683) (3,193) Benefit obligation at end of year $ 54,252 $ 53,433 Change in plan assets: Beginning fair value of plan assets $ — $ — Company contributions 3,103 2,579 Participant contributions 580 614 Benefits paid (3,683) (3,193) Ending fair value of plan assets $ — $ — Funded status at end of year $ (54,252) $ (53,433) Amounts recognized in financial statements: Accrued benefit liability $ (2,890) $ (2,800) Long-term postretirement obligations (51,362) (50,633) Total amount recognized in financial statements $ (54,252) $ (53,433)
Summary of Accumulated Other Comprehensive Loss	The following table summarizes the changes in accumulated other comprehensive (gain) loss: 2024 2023 Balance at beginning of year $ (12,336) $ (5,035) Net (gain) loss arising during the year 623 (7,301) Net gain (loss) recognized during the year 591 — Balance at end of year $ (11,122) $ (12,336)
Components of Net Periodic Benefits Cost	Net postretirement benefit costs include the following components: 2024 2023 2022 Service cost $ 281 $ 399 $ 687 Interest cost 3,018 3,063 1,923 Amortization of net actuarial (gain) loss (591) — 978 Total benefit cost (credit) $ 2,708 $ 3,462 $ 3,588
Weighted Average Assumptions Representing the Rates Used to Develop the Actuarial Present Value of Projected Benefit Obligation and the Net Periodic Benefit Costs	The weighted average assumptions used in the valuation of postretirement benefits were as follows: 2024 2023 2022 Assumptions used to determine benefit obligations at October 31: Discount rate 5.18 % 6.02 % 5.59 % Health care cost trend rate 2.25 3.40 3.50 Rate to which health care cost trend rate is assumed to incline/decline (ultimate trend rate) 1.80 3.16 3.19 Year the rate reaches the ultimate trend rate 2033 2032 2032 Assumption used to determine net benefit costs for the years ended October 31: Discount rate benefit obligation 6.02 % 5.59 % 2.98 % Discount rate service cost 6.26 6.00 3.55 Discount rate interest cost 5.76 5.22 2.30
Retiree Pension Benefit Payments	Retiree postretirement benefit payments are anticipated to be paid as follows: Year 2025 $ 2,890 2026 $ 3,021 2027 $ 3,203 2028 $ 3,331 2029 $ 3,455 2030-2034 $ 18,876

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Tax Expense	Income before income taxes and income tax expense (benefit) are comprised of the following: 2024 2023 2022 Income before income taxes: Domestic $ 314,263 $ 269,934 $ 302,549 Foreign 271,218 345,405 346,730 Total income before income taxes $ 585,481 $ 615,339 $ 649,279 Current: U.S. federal $ 65,085 $ 54,157 $ 59,639 State and local 2,017 285 7,535 Foreign 69,652 89,520 79,734 Total current 136,754 143,962 146,908 Deferred: U.S. federal (11,622) (9,119) (9,408) State and local (1,387) (1,279) (596) Foreign (5,548) (5,718) (728) Total deferred (18,557) (16,116) (10,732) $ 118,197 $ 127,846 $ 136,176
Income Taxes Computed at the U.S. Statutory Rate and Income Tax	A reconciliation of the U.S. statutory federal rate to the worldwide consolidated effective tax rate follows: 2024 2023 2022 Statutory federal income tax rate 21.00 % 21.00 % 21.00 % Share-based and other compensation (0.02) (0.25) 0.26 Foreign tax rate variances 1.22 1.83 0.95 State and local taxes, net of federal income tax benefit 0.08 (0.13) 0.84 Foreign-Derived Intangible Income Deduction (2.54) (2.24) (1.59) Global Intangible Low-Taxed Income net of foreign tax credits 0.40 0.71 0.23 Other – net 0.05 (0.14) (0.72) Effective tax rate 20.19 % 20.78 % 20.97 %
Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2024, 2023 and 2022 is as follows: 2024 2023 2022 Gross balance at beginning of year $ 8,002 $ 2,872 $ 3,720 Additions based on tax positions related to the current year 300 410 310 Additions for tax positions of prior years — 10 — Increases related to acquired businesses — 6,602 — Reductions for tax positions of prior years (418) — (70) Lapse of statute of limitations (403) (1,892) (1,088) Gross balance at end of year $ 7,481 $ 8,002 $ 2,872
Significant Components of Deferred Tax Assets and Liabilities	2024 2023 Deferred tax assets: Lease Liabilities $ 25,254 $ 26,678 Employee benefits 29,291 26,680 Tax credit and loss carryforwards 35,258 28,667 Other accruals not currently deductible for taxes 9,190 8,944 Inventory adjustments 16,634 5,932 Total deferred tax assets 115,627 96,901 Valuation allowance (33,596) (23,732) Total deferred tax assets 82,031 73,169 Deferred tax liabilities: Depreciation and amortization 256,183 238,210 Lease right-of-use assets 24,204 25,925 Other - net (3,865) 3,649 Total deferred tax liabilities 276,522 267,784 Net deferred tax liabilities $ (194,491) $ (194,615)

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Long-Term Debt	A summary of long-term debt is as follows: 2024 2023 Notes Payable $ 18,285 $ 5,019 Revolving credit agreement, due 2028 240,000 248,000 Term loan, due 2026 280,000 300,000 Senior notes, due 2025 8,500 32,000 Senior notes, due 2025-2027 37,143 54,286 Senior notes, due 2025-2030 190,000 260,000 5.600% Notes due 2028 350,000 350,000 5.800% Notes due 2033 500,000 500,000 4.500% Notes due 2029 600,000 — 2,223,928 1,749,305 Less current maturities 103,928 115,662 Less unamortized debt issuance costs 16,359 10,773 Less bond discounts 2,444 1,476 Long-term maturities $ 2,101,197 $ 1,621,394
Schedule of Line of Credit Facilities	Bank lines of credit are summarized as follows: 2024 2023 Maximum borrowings available under bank lines of credit (all foreign banks) $ 123,983 $ 114,464 Outstanding borrowings / notes payable (all foreign bank debt) (18,285) (5,019) Unused bank lines of credit $ 105,698 $ 109,445

Leases (Tables)

Leases (Tables)	12 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Lease Cost and Additional Lease Information	Additional lease information is summarized below for the twelve months ended October 31: October 31, 2024 October 31, 2023 Finance Leases Operating Leases Finance Leases Operating Leases Amortization of right of use assets $ 5,978 $ 5,926 Interest 505 357 Lease cost (1) 6,483 $ 20,133 6,283 $ 19,662 Short-term and variable lease cost (1) 3,019 2,908 2,338 1,989 Total lease cost $ 9,502 $ 23,041 $ 8,621 $ 21,651 (1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Supplemental cash flow information is summarized below for the twelve months ended October 31, 2024: Finance Leases Operating Leases Cash outflows for leases $ 6,148 $ 20,754 Weighted average remaining lease term (years) 6.70 8.06 Weighted average discount rate 3.08% 2.09%
Finance Lease, Liability, Fiscal Year Maturity	The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the Consolidated Balance Sheet as of October 31, 2024. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2025 $ 5,713 $ 18,784 2026 4,316 17,651 2027 2,957 14,164 2028 1,385 11,379 2029 469 10,062 Later years 4,175 34,646 Total minimum lease payments 19,015 106,686 Amounts representing interest 1,670 8,805 Present value of minimum lease payments $ 17,345 $ 97,881
Lessee, Operating Lease, Liability, Maturity	The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the Consolidated Balance Sheet as of October 31, 2024. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2025 $ 5,713 $ 18,784 2026 4,316 17,651 2027 2,957 14,164 2028 1,385 11,379 2029 469 10,062 Later years 4,175 34,646 Total minimum lease payments 19,015 106,686 Amounts representing interest 1,670 8,805 Present value of minimum lease payments $ 17,345 $ 97,881

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Oct. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: October 31, 2024 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 3,332 $ — $ 3,332 $ — Net investment contracts (b) 6,049 — 6,049 — Total assets at fair value $ 9,381 $ — $ 9,381 $ — Liabilities: Deferred compensation plans (c) $ 9,615 $ — $ 9,615 $ — Net investment contracts (b) 20,261 — 20,261 — Foreign currency forward contracts (a) 5,508 — 5,508 — Total liabilities at fair value $ 35,384 $ — $ 35,384 $ — October 31, 2023 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 696 $ — $ 696 $ — Net investment contracts (b) 13,713 — 13,713 — Total assets at fair value $ 14,409 $ — $ 14,409 $ — Liabilities: Deferred compensation plans (c) $ 9,637 $ — $ 9,637 $ — Net investment contracts (b) 9,985 — 9,985 — Foreign currency forward contracts (a) 10,425 — 10,425 — Total liabilities at fair value $ 30,047 $ — $ 30,047 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The fair value of these hedges is primarily based on the exchange rate between the currency pair of the hedge upon which settlement is based and includes an adjustment for the counterparty’s or Company’s credit risk. The notional amount of our net investment hedge contracts as of October 31, 2024 was $845,333. (c) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable	The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. 2024 2023 Carrying Fair Value Carrying Fair Value Long-term debt (including current portion) $ 2,186,840 $ 2,219,414 $ 1,732,037 $ 1,699,187

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Oct. 31, 2024
Investments, All Other Investments [Abstract]
Outstanding Currency, Forward Exchange Contracts	The following table summarizes, by currency, the contracts outstanding at October 31, 2024 and 2023: Notional Amounts Sell Buy October 31, 2024 contract amounts: Euro $ 156,836 $ 171,840 Pound sterling 22,043 168,763 Japanese yen 24,559 29,943 Mexican peso 1,732 27,996 Hong Kong dollar 1,946 1,961 Singapore dollar 73 21,472 Australian dollar — 10,167 Taiwan dollar — 8,000 Other 8,389 75,686 Total $ 215,578 $ 515,828 October 31, 2023 contract amounts: Euro $ 107,056 $ 53,919 Pound sterling 17,449 163,116 Japanese yen 18,858 22,088 Mexican peso 45 26,063 Hong Kong dollar 1,509 8,943 Singapore dollar 448 20,126 Australian dollar — 9,112 Taiwan Dollar — 8,000 Other 14,518 79,814 Total $ 159,883 $ 391,181
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location	The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheet as of October 31, 2024: Prepaid expenses and other current assets Other assets Accrued liabilities Other long-term liabilities Net investment contracts $ 5,976 $ 73 $ 10,675 $ 9,586

Capital Shares (Tables)

Capital Shares (Tables)	12 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Capital Shares	Common shares repurchased as part of publicly announced programs during 2024, 2023 and 2022 were as follows: Year Number Total Average 2024 123 $ 28,198 $ 228.60 2023 373 79,786 213.62 2022 1,190 260,288 218.69

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summarized Activity Related to Stock Options	The following table summarizes activity related to stock options during 2024: Number of Weighted˗Average Aggregate Weighted˗Average Outstanding at October 31, 2023 1,062 $ 152.41 Granted 61 $ 238.35 Exercised (261) $ 121.80 Forfeited or expired (7) $ 229.54 Outstanding at October 31, 2024 855 $ 167.26 $ 70,409 4.7 years Expected to vest 164 $ 239.44 $ 2,110 7.8 years Exercisable at October 31, 2024 690 $ 149.97 $ 68,283 4.0 years
Summarized Information on Currently Outstanding Options	Summarized information on currently outstanding options follows: Range of Exercise Price $67 - $125 $126 - $190 $191 - $268 Number outstanding 261 314 280 Weighted-average remaining contractual life, in years 3.0 4.5 7.4 Weighted-average exercise price $ 110.17 $ 154.44 $ 235.04 Number exercisable 261 313 116 Weighted-average exercise price $ 110.15 $ 154.36 $ 227.51
Fair Value Assumptions of Stock Options	The fair value of each option grant was estimated at the date of the grant using the Black-Scholes option-pricing model with the following assumptions: 2024 2023 2022 Expected volatility 30.3%-31.7% 30.4%-31.8% 30.6%-30.8% Expected dividend yield 1.15%-1.20% 1.12%-1.27% 0.76%-0.89% Risk-free interest rate 4.22%-4.52% 3.79%-4.21% 1.36%-2.65% Expected life of the option (in years) 5.0-6.2 5.0-6.2 5.3-6.2
Summarized Activity Related to Restricted Stock Units	The following table summarizes activity related to restricted share units in 2024: Number of Weighted˗Average Grant Date Fair Restricted share units at October 31, 2023 69 $ 236.28 Granted 41 $ 235.53 Forfeited (6) $ 241.89 Vested (37) $ 229.72 Restricted share units at October 31, 2024 67 $ 238.83
Summarized Activity Related to Director Deferred Compensation Shares	The following table summarizes activity related to director deferred compensation share equivalent units during 2024: Number of Weighted˗Average Outstanding at October 31, 2023 78 $ 93.11 Restricted stock units vested 5 $ 215.81 Dividend equivalents 1 $ 249.07 Distributions (19) $ 54.54 Outstanding at October 31, 2024 65 $ 115.66

Operating Segments and Geogra_2

Operating Segments and Geographic Area Data (Tables)	12 Months Ended
	Oct. 31, 2024
Segment Reporting [Abstract]
Reportable Segments	The following table presents information about our reportable segments: Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Solutions Corporate Total Year ended October 31, 2024 Net external sales $ 1,484,249 $ 695,452 $ 510,220 $ — $ 2,689,921 Depreciation and amortization 56,856 58,061 13,433 7,825 136,175 Operating profit (loss) 470,559 187,731 94,231 (78,520) 674,001 Identifiable assets (a) 1,926,426 2,267,239 697,224 1,184,222 6,075,111 Property, plant and equipment expenditures 16,892 19,533 4,269 23,716 64,410 Year ended October 31, 2023 Net external sales $ 1,391,046 $ 660,316 $ 577,270 $ — $ 2,628,632 Depreciation and amortization 33,228 54,988 15,185 8,497 111,898 Operating profit (loss) 460,889 189,367 101,662 (79,157) 672,761 Identifiable assets (a) 1,932,527 1,544,456 730,192 1,105,471 5,312,646 Property, plant and equipment expenditures 9,257 15,716 4,209 5,401 34,583 Year ended October 31, 2022 Net external sales $ 1,337,242 $ 690,177 $ 562,859 $ — $ 2,590,278 Depreciation and amortization 27,891 54,674 8,780 8,578 99,923 Operating profit (loss) 434,476 217,199 133,253 (82,568) 702,360 Identifiable assets (a) 1,112,825 1,558,861 397,250 812,964 3,881,900 Property, plant and equipment expenditures 9,490 31,009 2,383 8,546 51,428 (a)
Sales and Long-lived Asset Information by Geographic Regions	We have significant sales and long-lived assets in the following geographic areas: 2024 2023 2022 Net external sales Americas $ 1,178,626 $ 1,149,760 $ 1,096,596 Europe 726,100 682,676 645,603 Asia Pacific 785,195 796,196 848,079 Total net external sales $ 2,689,921 $ 2,628,632 $ 2,590,278 Long-lived assets Americas $ 465,521 $ 328,312 $ 332,709 Europe 113,274 109,428 62,039 Asia Pacific 59,432 61,282 60,973 Total long-lived assets $ 638,227 $ 499,022 $ 455,721
Summary of Reconciliation of Consolidated Assets	A reconciliation of total assets for reportable segments to total consolidated assets is as follows: 2024 2023 2022 Total identifiable assets for reportable segments $ 6,075,111 $ 5,312,646 $ 3,881,900 Eliminations (74,145) (60,876) (61,525) Total consolidated assets $ 6,000,966 $ 5,251,770 $ 3,820,375

Supplemental Information for _2

Supplemental Information for the Statement of Cash Flows (Tables)	12 Months Ended
	Oct. 31, 2024
Cash and Cash Equivalents [Abstract]
Supplemental Information for the Statement of Cash Flows	2024 2023 2022 Cash operating activities: Interest paid $ 85,966 $ 54,710 $ 22,975 Income taxes paid 160,122 112,912 141,212

Significant Accounting Polici_4

Significant Accounting Policies - Additional Information (Detail) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Significant Accounting Policies [Line Items]
Percent of revenue recognized over time	10%	10%
Advertising costs incurred	$ 8,923,000	$ 7,635,000	$ 7,028,000
Research and development costs incurred	$ 64,992,000	71,400,000	52,531,000
Periods of performance considered for calculating compensation expense	3 years
Accounts receivable, after allowance for credit loss	$ 9,769,000	10,015,000
Provision for losses on receivables	$ 619,000	283,000	1,259,000
Maturity of foreign currency forward contracts	90 days
Interest charges capitalized	$ 0	$ 0	$ 0
Product warranty period	1 year
Less than 50% Ownership Percentage, Accounted for under the Equity Method of Investment	50%
Maximum
Significant Accounting Policies [Line Items]
Liquid instruments with maturity period	90 days
Stock Options
Significant Accounting Policies [Line Items]
Options for common shares excluded from computation of diluted earning per share (in shares)	74,000	140,000	78,000

Significant Accounting Polici_5

Significant Accounting Policies - Useful Lives of Property, Plant and Equipment and Depreciation (Detail)	Oct. 31, 2024
Minimum | Land improvements
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	15 years
Minimum | Buildings
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	20 years
Minimum | Machinery and equipment
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	3 years
Minimum | Enterprise management system
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	5 years
Maximum | Land improvements
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	25 years
Maximum | Buildings
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	40 years
Maximum | Machinery and equipment
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	18 years
Maximum | Enterprise management system
Property Plant and Equipment [Line Items]
Useful lives of property, plant and equipment and depreciation	13 years

Significant Accounting Polici_6

Significant Accounting Policies - Weighted Average Useful Lives for Each Major Category of Amortizable Intangible Assets (Detail)	Oct. 31, 2024
Patent/Technology Costs
Finite-Lived Intangible Assets [Line Items]
Weighted average useful lives for each major category of amortizable intangible assets	11 years
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Weighted average useful lives for each major category of amortizable intangible assets	17 years
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Weighted average useful lives for each major category of amortizable intangible assets	4 years
Trade Names
Finite-Lived Intangible Assets [Line Items]
Weighted average useful lives for each major category of amortizable intangible assets	10 years

Significant Accounting Polici_7

Significant Accounting Policies - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning balance	$ (196,441)
Pension and postretirement plan changes, net of tax	(4,789)
Currency translation losses	16,390	$ 26,766	$ (126,657)
Accumulated other comprehensive loss, Ending balance	(184,840)	(196,441)
Pension and postretirement plan changes, tax	1,716
Cumulative Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning balance	(133,280)
Currency translation losses	16,390
Accumulated other comprehensive loss, Ending balance	(116,890)	(133,280)
Pension And Postretirement Benefit Plan Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning balance	(63,161)
Pension and postretirement plan changes, net of tax	(4,789)
Accumulated other comprehensive loss, Ending balance	$ (67,950)	$ (63,161)

Significant Accounting Polici_8

Significant Accounting Policies - Reconciliation of Product Warranty Liability (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Balance at beginning of year	$ 14,401	$ 11,723
Accruals for warranties	14,965	20,910
Warranty payments	(15,717)	(16,171)
Currency adjustments	(111)	(2,061)
Balance at end of year	$ 13,538	$ 14,401

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail)						12 Months Ended
	Aug. 21, 2024 USD ($)	Aug. 24, 2023 USD ($)	Aug. 24, 2023 EUR (€)	Nov. 03, 2022 USD ($)	Nov. 01, 2021 USD ($)	Oct. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)	Oct. 31, 2022 USD ($)
Business Acquisition [Line Items]
Goodwill						$ 3,280,819,000	$ 2,784,201,000	$ 1,804,693,000
Acquisition of businesses, net of cash acquired						$ 789,996,000	$ 1,422,780,000	$ 171,613,000
Atrion Corporation
Business Acquisition [Line Items]
Goodwill	$ 494,279,000
Intangibles	129,600,000
Cash acquisition	789,996,000
Cash	24,428,000
Atrion Corporation | Trade Names
Business Acquisition [Line Items]
Intangibles	$ 40,100,000
Atrion Corporation | Trade Names | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life	15 years
Atrion Corporation | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles	$ 24,900,000
Atrion Corporation | Technology-Based Intangible Assets | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life	15 years
Atrion Corporation | Customer Relationships
Business Acquisition [Line Items]
Intangibles	$ 64,600,000
Atrion Corporation | Customer Relationships | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life	19 years
ARAG Group
Business Acquisition [Line Items]
Goodwill		$ 684,938,000
Intangibles		353,500,000
Debt Repayment of Acquired Company | €			€ 30,300,000
Cash		32,966,000
ARAG Group | Euro
Business Acquisition [Line Items]
Cash acquisition | €			€ 957,000,000
ARAG Group | Trade Names
Business Acquisition [Line Items]
Intangibles		$ 27,500,000
ARAG Group | Trade Names | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life		9 years	9 years
ARAG Group | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles		$ 31,000,000
ARAG Group | Technology-Based Intangible Assets | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life		5 years	5 years
ARAG Group | Customer Relationships
Business Acquisition [Line Items]
Intangibles		$ 295,000,000
ARAG Group | Customer Relationships | Acquisitions In Two Thousand Twenty Three Member
Business Acquisition [Line Items]
Weighted average useful life		22 years	22 years
CyberOptics Corporation
Business Acquisition [Line Items]
Goodwill				$ 285,330,000
Intangibles				$ 58,600,000
Acquired percent of the outstanding shares				100%
Acquisition of businesses, net of cash acquired				$ 377,843,000
Cash				40,890,000
CyberOptics Corporation | Trade Names
Business Acquisition [Line Items]
Intangibles				$ 15,200,000
CyberOptics Corporation | Trade Names | Acquisitions In Two Thousand Twenty Two Member
Business Acquisition [Line Items]
Weighted average useful life				15 years
CyberOptics Corporation | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles				$ 14,600,000
CyberOptics Corporation | Technology-Based Intangible Assets | Acquisitions In Two Thousand Twenty Two Member
Business Acquisition [Line Items]
Weighted average useful life				7 years
CyberOptics Corporation | Customer Relationships
Business Acquisition [Line Items]
Intangibles				$ 28,800,000
CyberOptics Corporation | Customer Relationships | Acquisitions In Two Thousand Twenty Two Member
Business Acquisition [Line Items]
Weighted average useful life				12 years
NDC Technologies | Acquisitions In Two Thousand Twenty One Member
Business Acquisition [Line Items]
Goodwill					$ 131,129,000
Intangibles					$ 31,130,000
Acquired percent of the outstanding shares					100%
Acquisition of businesses, net of cash acquired					$ 171,613,000
Cash					7,533,000
Business combination, consideration transferred, other					2,763,000
Business combination, goodwill, tax deductible amount					72,018,000
NDC Technologies | Trade Names | Acquisitions In Two Thousand Twenty One Member
Business Acquisition [Line Items]
Intangibles					$ 10,800,000
Weighted average useful life					13 years
NDC Technologies | Technology-Based Intangible Assets | Acquisitions In Two Thousand Twenty One Member
Business Acquisition [Line Items]
Intangibles					$ 10,000,000
Weighted average useful life					7 years
NDC Technologies | Customer Relationships | Acquisitions In Two Thousand Twenty One Member
Business Acquisition [Line Items]
Intangibles					$ 9,500,000
Weighted average useful life					4 years
NDC Technologies | Non-compete Agreements | Acquisitions In Two Thousand Twenty One Member
Business Acquisition [Line Items]
Intangibles					$ 830,000
Weighted average useful life					3 years
364-Day Term Loan Facility
Business Acquisition [Line Items]
Other Loans Payable, Current	$ 500,000,000
Loans Payable, Current		$ 760,000

Acquisitions - Schedule of Reco

Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Aug. 21, 2024	Aug. 24, 2023	Nov. 03, 2022	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 3,280,819	$ 2,784,201	$ 1,804,693
CyberOptics Corporation
Business Acquisition [Line Items]
Cash			$ 40,890
Receivables - net			21,364
Inventories - net			33,639
Goodwill			285,330
Intangibles			58,600
Other assets			13,768
Total Assets			453,591
Accounts payable			8,109
Deferred income taxes			14,826
Other liabilities			11,923
Total Liabilities			$ 34,858
ARAG Group
Business Acquisition [Line Items]
Cash		$ 32,966
Receivables - net		31,081
Inventories - net		54,252
Goodwill		684,938
Intangibles		353,500
Other assets		55,963
Total Assets		1,212,700
Accounts payable		18,915
Deferred income taxes		100,097
Other liabilities		15,785
Total Liabilities		$ 134,797
Atrion Corporation
Business Acquisition [Line Items]
Cash	$ 24,428
Receivables - net	20,883
Inventories - net	64,801
Goodwill	494,279
Intangibles	129,600
Other assets	158,059
Total Assets	892,050
Accounts payable	25,587
Deferred income taxes	31,221
Other liabilities	20,818
Total Liabilities	$ 77,626

Details of Consolidated Balan_3

Details of Consolidated Balance Sheet - Details of Consolidated Balance Sheet (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Receivables:
Accounts	$ 571,381	$ 558,393
Notes	595	662
Other	32,456	41,845
Receivables, total	604,432	600,901
Allowance for doubtful accounts	(9,769)	(10,015)
Receivables-net	594,663	590,886
Inventories:
Finished goods	256,465	233,552
Raw materials and component parts	250,477	211,874
Work-in-process	55,790	86,474
Inventories gross	562,732	531,900
Obsolescence and other reserves	(85,797)	(77,125)
Inventories net	476,935	454,775
Property, plant and equipment:
Property, plant and equipment gross	1,182,371	970,630
Accumulated depreciation	(637,764)	(577,784)
Property, plant and equipment - net	544,607	392,846
Accrued liabilities:
Salaries and other compensation	77,799	63,130
Interest Payable, Current	13,800	11,240
Taxes other than income taxes	13,560	14,894
Warranty	13,538	14,401	$ 11,723
Net Investment Contracts	10,675	0
Pension and other employee benefits	8,919	8,686
Commissions and rebates	6,844	8,823
Foreign Currency Forward Contracts, Current	5,508	10,425
Other	74,588	67,989
Accrued liabilities total	225,231	199,588
Land
Property, plant and equipment:
Property, plant and equipment gross	32,018	15,792
Land improvements
Property, plant and equipment:
Property, plant and equipment gross	4,822	5,019
Buildings
Property, plant and equipment:
Property, plant and equipment gross	354,854	294,267
Machinery and equipment
Property, plant and equipment:
Property, plant and equipment gross	649,510	549,291
Enterprise management system
Property, plant and equipment:
Property, plant and equipment gross	53,401	52,939
Construction-in-progress
Property, plant and equipment:
Property, plant and equipment gross	58,362	24,916
Leased property under finance leases
Property, plant and equipment:
Property, plant and equipment gross	$ 29,404	$ 28,406

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Summary of Changes in Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Goodwill [Line Items]
Beginning balance	$ 2,784,201	$ 1,804,693
Acquisitions	484,317	980,230
Currency effect	12,301	(722)
Ending balance	3,280,819	2,784,201
Industrial Precision Solutions
Goodwill [Line Items]
Beginning balance	1,208,996	520,236
Acquisitions	(9,962)	694,900
Currency effect	8,597	(6,140)
Ending balance	1,207,631	1,208,996
Medical Fluid Systems
Goodwill [Line Items]
Beginning balance	1,173,858	1,172,069
Acquisitions	494,279	0
Currency effect	1,611	1,789
Ending balance	1,669,748	1,173,858
Advanced Technology Solutions
Goodwill [Line Items]
Beginning balance	401,347	112,388
Acquisitions	0	285,330
Currency effect	2,093	3,629
Ending balance	$ 403,440	$ 401,347

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	$ 1,286,588	$ 1,135,513
Accumulated Amortization	545,742	462,769
Net Book Value	740,846	672,744
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	878,071	794,706
Accumulated Amortization	339,756	287,585
Net Book Value	538,315	507,121
Patent/Technology Costs
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	232,371	204,905
Accumulated Amortization	134,187	112,994
Net Book Value	98,184	91,911
Trade Names
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	167,144	125,692
Accumulated Amortization	62,887	52,488
Net Book Value	104,257	73,204
Non-compete Agreements
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	8,502	10,028
Accumulated Amortization	8,412	9,521
Net Book Value	90	507
Other
Finite-Lived Intangible Assets [Line Items]
Carrying Amount	500	182
Accumulated Amortization	500	181
Net Book Value	$ 0	$ 1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, amortization expense	$ 76,972	$ 59,719	$ 50,825

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Estimated Amortization Expense (Detail) $ in Thousands	Oct. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 77,220
2026	73,639
2027	70,807
2028	68,239
2029	$ 62,334

Retirement, Pension and Other_3

Retirement, Pension and Other Postretirement Plans - Additional Information (Detail)	3 Months Ended	12 Months Ended
	Apr. 30, 2023 USD ($)	Oct. 31, 2024 USD ($)	Oct. 31, 2023 USD ($)	Oct. 31, 2022 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan vesting period		3 years
Expenses on retirement plan		$ 30,564,000	$ 29,511,000	$ 26,635,000
Pension settlement charge for U.S. Plans		$ (151,000)	335,000	(298,000)
Retiree eligible age		65 years
Pension settlement charge for U.S. Plans		$ 0	$ 0	(41,221,000)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]			Pension settlement charge for U.S. Plans
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Method used to amortize net gains and losses, description		Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when exceeding the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations.
Employer contribution in next fiscal year		$ 3,726,000
Retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Method used to amortize net gains and losses, description		Net actuarial gains or losses are amortized to expense on a plan-by-plan basis when exceeding the accounting corridor, which is set at 10 percent of the greater of the plan assets or benefit obligations.
Employer contribution in next fiscal year		$ 2,896,000
UNITED STATES | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Pension settlement charge for U.S. Plans		$ (56,000)	$ (90,000)	(41,548,000)
Percentage of World wide pension assets		89%
Defined Benefit Plan, Number of Pension Plans	2
Fair value of plan assets	$ 171,181	$ 366,042,000	321,676,000	333,851,000
Number of retirees and Beneficiaries	1,500
UNITED STATES | Retirement Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0	0
International | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Pension settlement charge for U.S. Plans		$ (95,000)	$ 425,000	$ 29,000
Weighted average crediting rates		1.10%	0.70%	0.60%
Percentage of World wide pension assets		11%
Fair value of plan assets		$ 44,829,000	$ 39,863,000	$ 38,316,000
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Percentage of target rate in return seeking assets		30%
Debt securities
Defined Benefit Plan Disclosure [Line Items]
Percentage of target rate in return seeking assets		70%

Retirement, Pension and Other_4

Retirement, Pension and Other Postretirement Plans - Reconciliation of the Benefit Obligations, Plan Assets, Accrued Benefit Cost and the Amount Recognized in Financial Statements for Pension Plans (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Pension Plans | UNITED STATES
Change in benefit obligation:
Benefit obligation at beginning of year	$ 319,186	$ 303,520
Service cost	10,043	10,973	$ 16,820
Interest cost	18,975	16,699	14,486
Participant contributions	0	0
Settlements	(1,659)	(1,499)
Curtailments	0	0
Foreign currency exchange rate change	0	0
Actuarial (gain) loss	30,709	(4,120)
Benefits paid	(8,906)	(6,387)
Benefit obligation at end of year	368,348	319,186	303,520
Change in plan assets:
Beginning balance	321,676	333,851
Actual return on plan assets	52,744	(6,307)
Company contributions	2,187	2,018
Participant contributions	0	0
Settlements	(1,659)	(1,499)
Foreign currency exchange rate change	0	0
Benefits paid	(8,906)	(6,387)
Ending balance	366,042	321,676	333,851
Funded status at end of year	(2,306)	2,490
Amounts recognized in financial statements:
Noncurrent asset	7,320	11,473
Accrued benefit liability	(977)	(1,494)
Long-term pension obligations	(8,649)	(7,489)
Total amount recognized in financial statements	(2,306)	2,490
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]
Net actuarial loss (gain)	107,027	102,506
Prior service cost (credit)	0	0
Accumulated other comprehensive loss (income)	107,027	102,506	74,293
Pension Plans | International
Change in benefit obligation:
Benefit obligation at beginning of year	62,813	60,880
Service cost	942	1,096	1,693
Interest cost	2,766	2,513	1,105
Participant contributions	82	79
Settlements	(805)	(607)
Curtailments	0	(2)
Foreign currency exchange rate change	2,320	3,566
Actuarial (gain) loss	4,086	(2,361)
Benefits paid	(2,841)	(2,351)
Benefit obligation at end of year	69,363	62,813	60,880
Change in plan assets:
Beginning balance	39,863	38,316
Actual return on plan assets	4,460	117
Company contributions	2,104	2,429
Participant contributions	82	79
Settlements	(805)	(607)
Foreign currency exchange rate change	1,966	1,880
Benefits paid	(2,841)	(2,351)
Ending balance	44,829	39,863	38,316
Funded status at end of year	(24,534)	(22,950)
Amounts recognized in financial statements:
Noncurrent asset	13,716	9,991
Accrued benefit liability	(6)	(5)
Long-term pension obligations	(38,244)	(32,936)
Total amount recognized in financial statements	(24,534)	(22,950)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]
Net actuarial loss (gain)	(2,312)	(3,122)
Prior service cost (credit)	(88)	(91)
Accumulated other comprehensive loss (income)	(2,400)	(3,213)	(2,413)
Retirement Plans | UNITED STATES
Change in benefit obligation:
Benefit obligation at beginning of year	53,433	59,851
Service cost	281	399	687
Interest cost	3,018	3,063	1,923
Participant contributions	580	614
Actuarial (gain) loss	623	(7,301)
Benefits paid	(3,683)	(3,193)
Benefit obligation at end of year	54,252	53,433	59,851
Change in plan assets:
Beginning balance	0	0
Company contributions	3,103	2,579
Participant contributions	580	614
Benefits paid	(3,683)	(3,193)
Ending balance	0	0	0
Funded status at end of year	(54,252)	(53,433)
Amounts recognized in financial statements:
Accrued benefit liability	(2,890)	(2,800)
Long-term pension obligations	(51,362)	(50,633)
Total amount recognized in financial statements	(54,252)	(53,433)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]
Accumulated other comprehensive loss (income)	$ (11,122)	$ (12,336)	$ (5,035)

Retirement, Pension and Other_5

Retirement, Pension and Other Postretirement Plans - Summary of Changes in Accumulated Other Comprehensive (Gain) Loss (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Pension Plans | UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Balance at beginning of year	$ 102,506	$ 74,293
Net loss (gain) arising during the year	4,577	28,303
Net (gain) recognized during the year	0	0
Prior service adjustment recognized during the year	0	0
Settlement (gain) loss	(56)	(90)
Curtailment (gain) loss	0	0
Exchange rate effect during the year	0	0
Balance at end of year	107,027	102,506
Pension Plans | International
Defined Benefit Plan Disclosure [Line Items]
Balance at beginning of year	(3,213)	(2,413)
Net loss (gain) arising during the year	1,197	(943)
Net (gain) recognized during the year	(29)	(79)
Prior service adjustment recognized during the year	(8)	(50)
Settlement (gain) loss	(95)	425
Curtailment (gain) loss	0	2
Exchange rate effect during the year	(268)	(255)
Balance at end of year	(2,400)	(3,213)
Retirement Plans | UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Balance at beginning of year	(12,336)	(5,035)
Net loss (gain) arising during the year	623	(7,301)
Net (gain) recognized during the year	591	0
Balance at end of year	$ (11,122)	$ (12,336)

Retirement, Pension and Other_6

Retirement, Pension and Other Postretirement Plans - Accumulated Benefit Obligation (Detail) - Pension Plans - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
UNITED STATES
For all plans:
Accumulated benefit obligation	$ 10,121	$ 8,703
Fair value of plan assets	0	0
For plans with projected benefit obligation in excess of plan assets:
Projected benefit obligation	9,626	8,983
Fair value of plan assets	0	0
International
For all plans:
Accumulated benefit obligation	41,647	36,413
Fair value of plan assets	5,323	5,115
For plans with projected benefit obligation in excess of plan assets:
Projected benefit obligation	43,574	38,039
Fair value of plan assets	$ 5,323	$ 5,115

Retirement, Pension and Other_7

Retirement, Pension and Other Postretirement Plans - Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Settlement loss (gain)	$ 151	$ (335)	$ 298
Pension Plans | UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Service cost	10,043	10,973	16,820
Interest cost	18,975	16,699	14,486
Expected return on plan assets	(26,611)	(26,116)	(27,776)
Amortization of prior service credit	0	0	48
Amortization of net actuarial loss	0	0	7,504
Settlement loss (gain)	56	90	41,548
Curtailment (gain) loss	0	0	0
Total benefit cost	2,463	1,646	52,630
Pension Plans | International
Defined Benefit Plan Disclosure [Line Items]
Service cost	942	1,096	1,693
Interest cost	2,766	2,513	1,105
Expected return on plan assets	(1,626)	(1,532)	(1,430)
Amortization of prior service credit	(8)	(50)	(104)
Amortization of net actuarial loss	29	79	2,278
Settlement loss (gain)	95	(425)	(29)
Curtailment (gain) loss	0	2	2,112
Total benefit cost	$ 2,198	$ 1,679	$ 1,401

Retirement, Pension and Other_8

Retirement, Pension and Other Postretirement Plans - Weighted Average Assumptions Representing the Rates Used to Develop the Actuarial Present Value of Projected Benefit Obligation and the Net Periodic Benefit Costs (Detail)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Pension Plans | UNITED STATES
Assumptions used to determine benefit obligations at October 31:
Discount rate	5.27%	6.08%	5.70%
Rate of compensation increase	3.96%	3.92%	4.30%
Assumptions used to determine net benefit costs for the years ended October 31:
Discount rate - benefit obligation	6.08%	5.70%	3.02%
Discount rate - service cost	6.18%	5.89%	3.42%
Discount rate - interest cost	5.84%	5.37%	2.35%
Expected return on plan assets	6.50%	6.40%	5.75%
Rate of compensation increase	3.92%	3.87%	4%
Pension Plans | International
Assumptions used to determine benefit obligations at October 31:
Discount rate	3.80%	4.35%	3.78%
Rate of compensation increase	3.08%	2.96%	3.44%
Assumptions used to determine net benefit costs for the years ended October 31:
Discount rate - benefit obligation	4.35%	3.78%	1.30%
Discount rate - service cost	3.48%	2.88%	1.14%
Discount rate - interest cost	4.28%	3.85%	1.37%
Expected return on plan assets	4.04%	3.75%	3.29%
Rate of compensation increase	2.96%	3.44%	2.90%
Retirement Plans | UNITED STATES
Assumptions used to determine benefit obligations at October 31:
Discount rate	5.18%	6.02%	5.59%
Health care cost trend rate	2.25%	3.40%	3.50%
Rate to which health care cost trend rate is assumed to incline/decline (ultimate trend rate)	1.80%	3.16%	3.19%
Year the rate reaches the ultimate trend rate	2033	2032	2032
Assumptions used to determine net benefit costs for the years ended October 31:
Discount rate - benefit obligation	6.02%	5.59%	2.98%
Discount rate - service cost	6.26%	6%	3.55%
Discount rate - interest cost	5.76%	5.22%	2.30%

Retirement, Pension and Other_9

Retirement, Pension and Other Postretirement Plans - Allocation of Pension Plan Assets (Detail) - Pension Plans	Oct. 31, 2024	Oct. 31, 2023
UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	100%	100%
International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	100%	100%
Equity securities | UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	3%	3%
Equity securities | International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	0%	0%
Debt securities | UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	45%	43%
Debt securities | International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	0%	0%
Insurance contracts | UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	0%	0%
Insurance contracts | International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	17%	31%
Pooled investment funds | UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	51%	53%
Pooled investment funds | International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	82%	67%
Other | UNITED STATES
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	1%	1%
Other | International
Allocation of pension plan assets
Defined Benefit Plan, Actual Plan Asset Allocations	1%	2%

Retirement, Pension and Othe_10

Retirement, Pension and Other Postretirement Plans - Fair Values of Pension Plan Assets (Detail) - Pension Plans - USD ($)	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2023	Oct. 31, 2022
UNITED STATES
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 366,042,000	$ 321,676,000	$ 171,181	$ 333,851,000
UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	177,180,000	150,793,000
UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12,392,000	11,234,000
UNITED STATES | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	164,788,000	139,559,000
International
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	44,829,000	39,863,000		38,316,000
International | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,832,000	13,001,000
International | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	442,000	777,000
International | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,390,000	12,224,000
Cash | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	355,000
Cash | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	355,000
Cash | International | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	442,000	777,000
Cash | International | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	442,000	777,000
Money market funds | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		251,000
Money market funds | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		251,000
Basic materials | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	683,000	632,000
Basic materials | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	683,000	632,000
Consumer goods | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,788,000	1,614,000
Consumer goods | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,788,000	1,614,000
Financial | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,461,000	1,787,000
Financial | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,461,000	1,787,000
Healthcare | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,811,000	1,368,000
Healthcare | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,811,000	1,368,000
Industrial goods | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,021,000	1,403,000
Industrial goods | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,021,000	1,403,000
Technology | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,104,000	1,732,000
Technology | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2,104,000	1,732,000
U.S. Government | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	58,000,000	42,269,000
U.S. Government | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. Government | UNITED STATES | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	58,000,000	42,269,000
Corporate | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	100,909,000	94,650,000
Corporate | UNITED STATES | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	100,909,000	94,650,000
Other | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5,879,000	2,640,000
Other | UNITED STATES | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5,879,000	2,640,000
Insurance contracts | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,390,000	12,224,000		$ 18,066,000
Insurance contracts | International | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,390,000	12,224,000
Insurance contracts | International | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,390,000	12,224,000
Other | UNITED STATES | Total
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,524,000	2,092,000
Other | UNITED STATES | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,524,000	2,092,000
Real estate collective funds | UNITED STATES | Investments Measured at Net Asset Value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	33,270,000	42,780,000
Pooled investment funds | UNITED STATES | Investments Measured at Net Asset Value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	155,592,000	128,103,000
Pooled investment funds | International | Investments Measured at Net Asset Value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 36,997,000	$ 26,862,000

Retirement, Pension and Othe_11

Retirement, Pension and Other Postretirement Plans - Changes in Level 3 plan assets (Detail) - Level 3 - Pension Plans - Insurance contracts - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Beginning balance	$ 12,224	$ 18,066
Purchases	1,428	1,320
Sales	(7,010)	(8,007)
Defined Benefit Plan, Plan Assets, Settlements	214	607
Defined Benefit Plan, Unrealized losses	440	266
Foreign currency translation	522	1,186
Ending balance	$ 7,390	$ 12,224

Retirement, Pension and Othe_12

Retirement, Pension and Other Postretirement Plans - Retiree Pension Benefit Payments (Detail) $ in Thousands	Oct. 31, 2024 USD ($)
Pension Plans | UNITED STATES
Pension Plans Postretirement And Other Employee Benefits [Line Items]
2025	$ 10,851
2026	12,667
2027	14,587
2028	16,470
2029	18,297
2030-2034	117,167
Pension Plans | International
Pension Plans Postretirement And Other Employee Benefits [Line Items]
2025	2,988
2026	5,076
2027	3,955
2028	3,637
2029	3,934
2030-2034	20,033
Retirement Plans | UNITED STATES
Pension Plans Postretirement And Other Employee Benefits [Line Items]
2025	2,890
2026	3,021
2027	3,203
2028	3,331
2029	3,455
2030-2034	$ 18,876

Retirement, Pension and Othe_13

Retirement, Pension and Other Postretirement Plans - Net Postretirement Benefit Cost (Detail) - Retirement Plans - UNITED STATES - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 281	$ 399	$ 687
Interest cost	3,018	3,063	1,923
Amortization of net actuarial (gain) loss	(591)	0	978
Total benefit cost	$ 2,708	$ 3,462	$ 3,588

Income Taxes - Income Tax Expen

Income Taxes - Income Tax Expense (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Current:
U.S. federal	$ 65,085	$ 54,157	$ 59,639
State and local	2,017	285	7,535
Foreign	69,652	89,520	79,734
Total current	136,754	143,962	146,908
Deferred:
U.S. federal	(11,622)	(9,119)	(9,408)
State and local	(1,387)	(1,279)	(596)
Foreign	(5,548)	(5,718)	(728)
Total deferred	(18,557)	(16,116)	(10,732)
Income taxes	118,197	127,846	136,176
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	585,481	615,339	649,279
Earnings before income taxes of domestic operations	314,263	269,934	302,549
Earnings before income taxes of international operations	$ 271,218	$ 345,405	$ 346,730

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2021
Income Tax [Line Items]
Earnings before income taxes of domestic operations	$ 314,263	$ 269,934	$ 302,549
U.S. federal corporate income tax rate	21%	21%	21%
Earnings before income taxes of international operations	$ 271,218	$ 345,405	$ 346,730
Undistributed earnings aggregated	1,433,106	1,533,889
Total unrecognized tax benefits	7,481	8,002	$ 2,872	$ 3,720
Total unrecognized tax benefits impact the effective tax rate	6,670	4,497
Accrued interest expense related to unrecognized tax benefits	800	401
Tax credit carryforwards	20,367
Tax credit carryforwards amount indefinite carryforward period	5,251
Capital loss carryforward	4,459
Indefinite carryforward period	24,897
Net change in the valuation allowance	9,864	$ 13,602
Valuation allowance relates to tax credits and loss carryforwards	33,596
Expires in 2028
Income Tax [Line Items]
Tax credit carryforwards amount to expires	15,116
2022 through 2039
Income Tax [Line Items]
Operating loss carryforwards	58,426
State
Income Tax [Line Items]
Operating loss carryforwards	30,897
Foreign
Income Tax [Line Items]
Operating loss carryforwards	$ 47,966

Income Taxes - Income Taxes Com

Income Taxes - Income Taxes Computed at the U.S. Statutory Rate and Income Tax (Detail)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	21%	21%	21%
Share-based and other compensation	(0.02%)	(0.25%)	0.26%
Foreign tax rate variances	1.22%	1.83%	0.95%
State and local taxes, net of federal income tax benefit	0.08%	(0.13%)	0.84%
Foreign-Derived Intangible Income Deduction	(2.54%)	(2.24%)	(1.59%)
Global Intangible Low-Taxed Income net of foreign tax credits	0.40%	0.71%	0.23%
Other – net	0.05%	(0.14%)	(0.72%)
Effective tax rate	20.19%	20.78%	20.97%

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Gross balance at beginning of year	$ 8,002	$ 2,872	$ 3,720
Additions based on tax positions related to the current year	300	410	310
Additions for tax positions of prior years	0	10	0
Increases related to acquired businesses	0	6,602	0
Reductions for tax positions of prior years	(418)	0	(70)
Lapse of statute of limitations	(403)	(1,892)	(1,088)
Gross balance at end of year	$ 7,481	$ 8,002	$ 2,872

Income Taxes - Significant Comp

Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Deferred tax assets:
Lease Liabilities	$ 25,254	$ 26,678
Employee benefits	29,291	26,680
Other accruals not currently deductible for taxes	9,190	8,944
Tax credit and loss carryforwards	35,258	28,667
Inventory adjustments	16,634	5,932
Total deferred tax assets	115,627	96,901
Valuation allowance	(33,596)	(23,732)
Total deferred tax assets	82,031	73,169
Deferred tax liabilities:
Depreciation and amortization	256,183	238,210
Lease right-of-use assets	24,204	25,925
Other - net	(3,865)	3,649
Total deferred tax liabilities	276,522	267,784
Net deferred tax liabilities	$ (194,491)	$ (194,615)

Long-Term Debt - Long-Term Debt

Long-Term Debt - Long-Term Debt (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023	Jun. 06, 2023
Debt Instrument [Line Items]
Notes Payable	$ 18,285	$ 5,019
Bonds, due 2028		350,000
Bonds, due 2033		500,000
Long-term Debt	2,223,928	1,749,305
Current maturities of long-term debt and notes payable	103,928	115,662
Less unamortized debt issuance costs	16,359	10,773
Less bond discounts	2,444	1,476
Long-term debt	2,101,197	1,621,394
Senior notes, due 2025
Debt Instrument [Line Items]
Senior notes	8,500	32,000
Senior notes, due 2025-2027
Debt Instrument [Line Items]
Senior notes	37,143	54,286
Senior notes, due 2025-2030
Debt Instrument [Line Items]
Senior notes	190,000	260,000
Due 2028
Debt Instrument [Line Items]
Public bond offering	350,000
Due 2033
Debt Instrument [Line Items]
Public bond offering	500,000
Due 2029
Debt Instrument [Line Items]
Public bond offering	600,000	0
Revolving Credit Agreement Due 2028
Debt Instrument [Line Items]
Revolving credit agreement, due 2028	240,000	248,000
Term Loan Due 2026
Debt Instrument [Line Items]
Term loan	$ 280,000	$ 300,000	$ 300,000

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Detail) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Jun. 06, 2023	Apr. 30, 2019
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)			$ 1,150,000,000
Long-term debt, maturities, repayments of principal in next twelve months	$ 103,928,000
Annual maturity of long term debt, 2023	330,000,000
Long-term debt, maturities, repayments of principal in year three	10,000,000
Annual maturity of long term debt, 2025	630,000,000
Annual maturity of long term debt, 2026	$ 620,000,000
Senior notes, due 2025
Debt Instrument [Line Items]
Debt, weighted average interest rate	3.07%
Remaining weighted average life of notes	8 months 23 days
Senior notes, due 2025-2027
Debt Instrument [Line Items]
Debt, weighted average interest rate	3.13%
Remaining weighted average life of notes	1 year 6 months 18 days
Senior notes, due 2025-2030
Debt Instrument [Line Items]
Debt, weighted average interest rate	4.03%
Remaining weighted average life of notes	2 years 8 months 12 days
Due 2029
Debt Instrument [Line Items]
Debt, weighted average interest rate	4.50%
Public bond offering	$ 600,000,000	$ 0
Foreign Bank Debt
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)	$ 123,983,000	114,464,000
Revolving Credit Facility
Debt Instrument [Line Items]
Debt, weighted average interest rate	5.66%
Due 2028
Debt Instrument [Line Items]
Debt, weighted average interest rate	5.60%
Public bond offering	$ 350,000,000
Due 2033
Debt Instrument [Line Items]
Debt, weighted average interest rate	5.80%
Public bond offering	$ 500,000,000
Minimum | Revolving Credit Agreement Due 2028
Debt Instrument [Line Items]
EuroDollar base rate range	0.85%
Revolver base rate range			0%
Maximum | Revolving Credit Agreement Due 2028
Debt Instrument [Line Items]
EuroDollar base rate range			1.20%
Revolver base rate range			0.20%
Revolving Credit Agreement
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)				$ 850,000,000
Revolving Credit Agreement | Swing Line Loans
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)				$ 75,000,000
Revolving Credit Agreement Due 2028
Debt Instrument [Line Items]
Revolving facility maximum borrowing capacity			$ 850,000,000
Revolving facility increased maximum borrowing capacity			922,500,000
Revolving credit agreement, due 2028	$ 240,000,000	248,000,000
Term Loan Due 2026
Debt Instrument [Line Items]
Term loan	$ 280,000,000	$ 300,000,000	$ 300,000,000

Long-Term Debt - Bank Lines Of

Long-Term Debt - Bank Lines Of Credit (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023	Jun. 06, 2023
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)			$ 1,150,000
Notes Payable	$ (18,285)	$ (5,019)
Foreign Bank Debt
Debt Instrument [Line Items]
Maximum borrowings available under bank lines of credit (all foreign banks)	123,983	114,464
Unused bank lines of credit	$ 105,698	$ 109,445

Leases - Lease Cost and Additio

Leases - Lease Cost and Additional Lease Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Lease, Cost [Abstract]
Amortization of right of use assets	$ 5,978	$ 5,926
Interest	505	357
Finance Lease, Cost	6,483	6,283
Finance leases, Short-term and variable lease cost	3,019	2,338
Finance Leases, Lease, Cost	9,502	8,621
Operating lease cost	20,133	19,662
Operating leases, Short-term and variable lease cost	2,908	1,989
Total lease cost	$ 23,041	$ 21,651

Leases - Supplemental Informati

Leases - Supplemental Information for the Statement of Cash Flows (Details) $ in Thousands	12 Months Ended
	Oct. 31, 2024 USD ($)
Lease, Cost [Abstract]
Finance Lease, Principal Payments	$ 6,148
Finance Lease, Weighted Average Remaining Lease Term	6 years 8 months 12 days
Finance Lease, Weighted Average Discount Rate, Percent	3.08%
Operating Lease, Payments	$ 20,754
Operating Lease, Weighted Average Remaining Lease Term	8 years 21 days
Operating Lease, Weighted Average Discount Rate, Percent	2.09%

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Lessee, Lease, Description [Line Items]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$ 16,364	$ 16,310
Operating Lease, Expense	$ 21,184	$ 22,095	$ 20,479

Leases - Finance and Operating

Leases - Finance and Operating Lease Maturity (Details) $ in Thousands	Oct. 31, 2024 USD ($)
Finance Leases
2025	$ 5,713
2026	4,316
2027	2,957
2028	1,385
2029	469
Later years	4,175
Total minimum lease payments	19,015
Amounts representing interest	1,670
Present value of minimum lease payments	17,345
Operating Leases
2025	18,784
2026	17,651
2027	14,164
2028	11,379
2029	10,062
Later years	34,646
Total minimum lease payments	106,686
Amounts representing interest	8,805
Present value of minimum lease payments	$ 97,881

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Liabilities:
Derivative asset, notional amount	$ 845,333
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90%
Recurring
Assets:
Foreign currency forward contracts	$ 3,332	$ 696
Net investment contracts	6,049	13,713
Total assets at fair value	9,381	14,409
Liabilities:
Deferred compensation plans	9,615	9,637
Net investment contracts	20,261	9,985
Foreign currency forward contracts	5,508	10,425
Total liabilities at fair value	35,384	30,047
Recurring | Level 1
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Net investment contracts	0	0
Foreign currency forward contracts	0	0
Total liabilities at fair value	0	0
Recurring | Level 2
Assets:
Foreign currency forward contracts	3,332	696
Net investment contracts	6,049	13,713
Total assets at fair value	9,381	14,409
Liabilities:
Deferred compensation plans	9,615	9,637
Net investment contracts	20,261	9,985
Foreign currency forward contracts	5,508	10,425
Total liabilities at fair value	35,384	30,047
Recurring | Level 3
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Net investment contracts	0	0
Foreign currency forward contracts	0	0
Total liabilities at fair value	$ 0	$ 0

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Schedule Of Carrying Amounts And Fair Values Of Financial Instruments [Abstract]
Long-term debt (including current portion), Carrying Amount	$ 2,186,840	$ 1,732,037
Long-term debt (including current portion), Fair Value	$ 2,219,414	$ 1,699,187

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
	Sep. 04, 2024	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Derivative [Line Items]
Maturity of foreign currency forward contracts		90 days
Gain (loss) on foreign currency derivative instruments		$ 7,553	$ (3,041)	$ (4,937)
Change in unrealized gain loss on foreign currency derivative instruments		(13,052)	(4,701)	$ 11,207
Net Investment Hedge Gain (Loss)		(16,214)
Net Investment Hedge Tax Amount		5,366
Due 2029
Derivative [Line Items]
Public bond offering		$ 600,000	$ 0
Treasury Lock	$ 250,000
Treasury Lock Cash Settlement	$ 2,306

Derivative Financial Instrume_4

Derivative Financial Instruments - Outstanding Currency, Forward Exchange Contracts (Detail) - Foreign Currency Forward Contracts - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 215,578	$ 159,883
Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	515,828	391,181
Euro | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	156,836	107,056
Euro | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	171,840	53,919
Pound sterling | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	22,043	17,449
Pound sterling | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	168,763	163,116
Japanese yen | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	24,559	18,858
Japanese yen | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	29,943	22,088
Mexican peso | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	1,732	45
Mexican peso | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	27,996	26,063
Hong Kong dollar | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	1,946	1,509
Hong Kong dollar | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	1,961	8,943
Singapore dollar | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	73	448
Singapore dollar | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	21,472	20,126
Australian dollar | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0	0
Australian dollar | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	10,167	9,112
Taiwan dollar | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0	0
Taiwan dollar | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	8,000	8,000
Other | Sell
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	8,389	14,518
Other | Buy
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 75,686	$ 79,814

Derivative Financial Instrume_5

Derivative Financial Instruments - Summary of Fair Values of Net Investment Contracts (Details)	Oct. 31, 2024 USD ($)
Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Net investment contracts	$ 5,976,000
Other Assets
Derivative [Line Items]
Net investment contracts	73,000
Accrued Liabilities
Derivative [Line Items]
Net investment contracts	10,675,000
Other Noncurrent Liabilities
Derivative [Line Items]
Net investment contracts	$ 9,586,000

Capital Shares - Additional Inf

Capital Shares - Additional Information (Detail) - shares	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Equity [Line Items]
Convertible preferred shares, authorized (in shares)	10,000,000	10,000,000
Common shares, authorized (in shares)	160,000,000	160,000,000
Common shares, issued (in shares)	98,023,000	98,023,000
Common Shares Outstanding (in shares)	57,197,000	57,007,000
Preferred Class A
Equity [Line Items]
Convertible preferred shares, authorized (in shares)	10,000,000	10,000,000	10,000,000
Convertible preferred shares, outstanding (in shares)	0	0	0

Capital Shares - Capital Shares

Capital Shares - Capital Shares (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Equity [Abstract]
Number of Shares (in shares)	123	373	1,190
Total Amount	$ 28,198	$ 79,786	$ 260,288
Average per Share (in dollars per share)	$ 228.60	$ 213.62	$ 218.69

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized	900,000
Maximum number of common shares available for gran (in shares)	1,875,000
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90%
Number of common shares reserved for future issuance (in shares)	1,139,000
Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expense related to director deferred compensation	$ 321,000	$ 309,000	$ 305,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options exercisable beginning period	1 year
Option expiring period	10 years
Normal retirement age	65 years
Period for options considered to be forfeited for retirees	12 months
Termination period on death or disability of option holder	12 months
Compensation expense recognized	$ 4,616,000	$ 6,655,000	$ 7,265,000
Unrecognized compensation cost related to nonvested stock option	$ 4,981,000
Weighted average period expected to be amortized, non vested shares	2 years 9 months 18 days
Weighted-average expected volatility used	30.70%	30.60%	30.60%
Weighted average grant date fair value of stock options granted (in dollars per share)	$ 79.84	$ 77.99	$ 78.88
Total intrinsic value of options exercised	$ 35,620,000	$ 23,706,000	$ 15,376,000
Cash received from the exercise of stock options	$ 31,067,000	21,373,000	12,124,000
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage	25%
Restricted Shares and Restricted Share Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period	3 years
Restricted Shares and Restricted Share Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period	1 year
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Normal retirement age	65 years
Period for restricted shares and share units considered to be forfeited for retirees	12 months
Restricted shares termination period for disability or death	12 months
Unrecognized compensation cost related to nonvested restricted stock	$ 0
Expense related to nonvested common shares	0	336,000	1,096,000
Common share dividends amount included in compensation cost	$ 0	5,000	19,000
Restricted Stock Unit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period expected to be amortized, non vested shares	1 year 9 months 18 days
Period for pro-rata vesting of shares or units for non-employee directors	12 months
Unrecognized compensation cost related to nonvested restricted stock	$ 8,883,000
Expense related to nonvested common shares	$ 8,853,000	$ 8,765,000	8,403,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 238.83	$ 236.28
Performance Share Incentive Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 5,070,000	$ 6,543,000	$ 13,626,000
Award requisite service period	3 years
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 6,529,000
Performance Share Incentive Awards | Grant Date One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 229.58	$ 231.34	$ 260.60
Performance Share Incentive Awards | Grant Date Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 225.14	211.25	273.50
Performance Share Incentive Awards | Grant Date Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value		$ 214.51	$ 221.94
Deferred Compensation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common share dividends amount included in compensation cost	$ 97,000	$ 107,000	$ 72,000
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90%

Stock-Based Compensation - Summ

Stock-Based Compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares
Number of Options
Beginning balance (in shares) | shares	1,062
Granted (in shares) | shares	61
Exercised (in shares) | shares	(261)
Forfeited or expired (in shares) | shares	(7)
Ending balance (in shares) | shares	855
Expected to vest (in shares) | shares	164
Exercisable (in shares) | shares	690
Weighted˗Average Exercise Price Per Share
Beginning balance (in dollars per share) | $ / shares	$ 152.41
Granted (in dollars per share) | $ / shares	238.35
Exercised (in dollars per share) | $ / shares	121.80
Forfeited or expired (in dollars per share) | $ / shares	229.54
Ending balance (in dollars per share) | $ / shares	167.26
Expected to vest (in dollars per share) | $ / shares	239.44
Exercisable (in dollars per share) | $ / shares	$ 149.97
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Aggregate Intrinsic Value, Outstanding | $	$ 70,409
Aggregate Intrinsic Value, Expected to vest | $	2,110
Aggregate Intrinsic Value, Exercisable | $	$ 68,283
Weighted Average Remaining Term, Outstanding	4 years 8 months 12 days
Weighted Average Remaining Term, Expected to vest	7 years 9 months 18 days
Weighted Average Remaining Term, Exercisable	4 years

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summarized Information on Currently Outstanding Options (Detail) shares in Thousands	12 Months Ended
	Oct. 31, 2024 $ / shares shares
$67 - $125
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, Lower range limit (in dollars per share)	$ 67
Exercise price range, Upper range limit (in dollars per share)	125
$126 - $190
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, Lower range limit (in dollars per share)	126
Exercise price range, Upper range limit (in dollars per share)	190
$191 - $268
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, Lower range limit (in dollars per share)	191
Exercise price range, Upper range limit (in dollars per share)	$ 268
Stock Options | $67 - $125
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number outstanding (in shares) | shares	261
Weighted-average remaining contractual life, in years	3 years
Weighted-average exercise price (in dollars per share)	$ 110.17
Number exercisable (in shares) | shares	261
Weighted-average exercise price (in dollars per share)	$ 110.15
Stock Options | $126 - $190
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number outstanding (in shares) | shares	314
Weighted-average remaining contractual life, in years	4 years 6 months
Weighted-average exercise price (in dollars per share)	$ 154.44
Number exercisable (in shares) | shares	313
Weighted-average exercise price (in dollars per share)	$ 154.36
Stock Options | $191 - $268
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number outstanding (in shares) | shares	280
Weighted-average remaining contractual life, in years	7 years 4 months 24 days
Weighted-average exercise price (in dollars per share)	$ 235.04
Number exercisable (in shares) | shares	116
Weighted-average exercise price (in dollars per share)	$ 227.51

Stock-Based Compensation - Fair

Stock-Based Compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, Minimum	30.30%	30.40%	30.60%
Expected volatility, Maximum	31.70%	31.80%	30.80%
Risk-free interest rate, Minimum	4.22%	3.79%	1.36%
Risk-free interest rate, Maximum	4.52%	4.21%	2.65%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.15%	1.12%	0.76%
Expected life of the option (in years)	5 years	5 years	5 years 3 months 18 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.20%	1.27%	0.89%
Expected life of the option (in years)	6 years 2 months 12 days	6 years 2 months 12 days	6 years 2 months 12 days

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit shares in Thousands	12 Months Ended
	Oct. 31, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in shares) | shares	69
Granted (in shares) | shares	41
Forfeited (in shares) | shares	(6)
Vested (in shares) | shares	(37)
Ending balance (in shares) | shares	67
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance (in dollars per share) | $ / shares	$ 236.28
Granted (in dollars per share) | $ / shares	235.53
Forfeited (in dollars per share) | $ / shares	241.89
Vested (in dollars per share) | $ / shares	229.72
Ending balance (in dollars per share) | $ / shares	$ 238.83

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors - Deferred Compensation Share Equivalent Units shares in Thousands	12 Months Ended
	Oct. 31, 2024 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	78
Restricted share units vested (in shares) | shares	5
Dividend equivalents (in shares) | shares	1
Distributions (in shares) | shares	(19)
Ending balance (in shares) | shares	65
Weighted˗Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 93.11
Restricted share units vested (in dollars per share) | $ / shares	215.81
Dividend equivalents (in dollars per share) | $ / shares	249.07
Distributions (in dollars per share) | $ / shares	54.54
Ending balance (in dollars per share) | $ / shares	$ 115.66

Operating Segments and Geogra_3

Operating Segments and Geographic Area Data - Additional Information (Detail)	12 Months Ended
	Oct. 31, 2024 segment
Segment Reporting [Abstract]
Number of operating segments	3
Major customers	No single customer accounted for 10 percent or more of sales in 2024, 2023 or 2022.

Operating Segments and Geogra_4

Operating Segments and Geographic Area Data - Reportable Segments (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Segment Reporting Information [Line Items]
Net external sales	$ 2,689,921	$ 2,628,632	$ 2,590,278
Depreciation and amortization	136,175	111,898	99,923
Operating profit (loss)	674,001	672,761	702,360
Identifiable assets	6,000,966	5,251,770	3,820,375
Property, plant and equipment expenditures	64,410	34,583	51,428
Total identifiable assets for reportable segments	6,075,111	5,312,646	3,881,900
Operating Segments
Segment Reporting Information [Line Items]
Total identifiable assets for reportable segments	6,075,111	5,312,646	3,881,900
Operating Segments | Industrial Precision Solutions
Segment Reporting Information [Line Items]
Net external sales	1,484,249	1,391,046	1,337,242
Depreciation and amortization	56,856	33,228	27,891
Operating profit (loss)	470,559	460,889	434,476
Identifiable assets	1,926,426	1,932,527	1,112,825
Property, plant and equipment expenditures	16,892	9,257	9,490
Operating Segments | Medical Fluid Systems
Segment Reporting Information [Line Items]
Net external sales	695,452	660,316	690,177
Depreciation and amortization	58,061	54,988	54,674
Operating profit (loss)	187,731	189,367	217,199
Identifiable assets	2,267,239	1,544,456	1,558,861
Property, plant and equipment expenditures	19,533	15,716	31,009
Operating Segments | Advanced Technology Solutions
Segment Reporting Information [Line Items]
Net external sales	510,220	577,270	562,859
Depreciation and amortization	13,433	15,185	8,780
Operating profit (loss)	94,231	101,662	133,253
Identifiable assets	697,224	730,192	397,250
Property, plant and equipment expenditures	4,269	4,209	2,383
Corporate
Segment Reporting Information [Line Items]
Net external sales	0	0	0
Depreciation and amortization	7,825	8,497	8,578
Operating profit (loss)	(78,520)	(79,157)	(82,568)
Identifiable assets	1,184,222	1,105,471	812,964
Property, plant and equipment expenditures	$ 23,716	$ 5,401	$ 8,546

Operating Segments and Geogra_5

Operating Segments and Geographic Area Data - Sales and Long-lived Asset Information by Geographic Regions (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Net external sales
Net external sales	$ 2,689,921	$ 2,628,632	$ 2,590,278
Long-lived assets
Total long-lived assets	638,227	499,022	455,721
Americas
Net external sales
Net external sales	1,178,626	1,149,760	1,096,596
Long-lived assets
Total long-lived assets	465,521	328,312	332,709
Europe
Net external sales
Net external sales	726,100	682,676	645,603
Long-lived assets
Total long-lived assets	113,274	109,428	62,039
Asia Pacific
Net external sales
Net external sales	785,195	796,196	848,079
Long-lived assets
Total long-lived assets	$ 59,432	$ 61,282	$ 60,973

Operating Segments and Geogra_6

Operating Segments and Geographic Area Data - Summary of Reconciliation of Consolidated Assets (Detail) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Segment Reporting, Asset Reconciling Item [Line Items]
Total identifiable assets for reportable segments	$ 6,075,111	$ 5,312,646	$ 3,881,900
Total consolidated assets	6,000,966	5,251,770	3,820,375
Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Total identifiable assets for reportable segments	6,075,111	5,312,646	3,881,900
Eliminations
Segment Reporting, Asset Reconciling Item [Line Items]
Total consolidated assets	$ (74,145)	$ (60,876)	$ (61,525)

Supplemental Information for _3

Supplemental Information for the Statement of Cash Flows - Supplemental Information for the Statement of Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Cash operating activities:
Interest paid	$ 85,966	$ 54,710	$ 22,975
Income taxes paid	$ 160,122	$ 112,912	$ 141,212

Contingencies -Additional (Deta

Contingencies -Additional (Details) - USD ($) $ in Thousands	Oct. 31, 2024	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Loss Contingencies Accrual	$ 181	$ 231

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts and Reserves (Detail) - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2022
Allowance for Doubtful Accounts
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	$ 10,015	$ 8,218	$ 7,552
Charged to Expense	619	283	1,259
Additions (Deductions)	(347)	1,469	(1,336)
Currency Effects	(518)	45	743
Balance at End of Year	9,769	10,015	8,218
Inventory Obsolescence and Other Reserves
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Balance at Beginning of Year	77,125	45,735	45,863
Charged to Expense	28,563	24,925	18,694
Additions (Deductions)	(20,063)	6,617	(18,372)
Currency Effects	172	(152)	(450)
Balance at End of Year	$ 85,797	$ 77,125	$ 45,735